{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import requests\n",
    "from time import time\n",
    "from matplotlib import pyplot as plt\n",
    "%matplotlib inline\n",
    "from nltk.tokenize import word_tokenize,RegexpTokenizer\n",
    "from nltk.corpus import stopwords\n",
    "from nltk.stem import WordNetLemmatizer\n",
    "import string\n",
    "from nltk import FreqDist\n",
    "from nltk.util import ngrams\n",
    "from nltk.tag import pos_tag\n",
    "import seaborn as sns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\carol\\anaconda3\\lib\\site-packages\\IPython\\core\\interactiveshell.py:3418: FutureWarning: The error_bad_lines argument has been deprecated and will be removed in a future version.\n",
      "\n",
      "\n",
      "  exec(code_obj, self.user_global_ns, self.user_ns)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>nct_id</th>\n",
       "      <th>study_type</th>\n",
       "      <th>phase</th>\n",
       "      <th>start_month_year</th>\n",
       "      <th>primary_completion_month_year</th>\n",
       "      <th>has_dmc</th>\n",
       "      <th>overall_status</th>\n",
       "      <th>official_title</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>why_stopped</th>\n",
       "      <th>...</th>\n",
       "      <th>keywords_name</th>\n",
       "      <th>enrollment</th>\n",
       "      <th>enrollment_index</th>\n",
       "      <th>enrollment_bins</th>\n",
       "      <th>minimum_age</th>\n",
       "      <th>minimum_age_years</th>\n",
       "      <th>minimum_age_int</th>\n",
       "      <th>minimum_age_bins</th>\n",
       "      <th>maximum_age</th>\n",
       "      <th>stopped</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT02330146</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 1/Phase 2</td>\n",
       "      <td>44331</td>\n",
       "      <td>44546</td>\n",
       "      <td>TRUE</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>A Randomized, Double-blind, Placebo-controlled...</td>\n",
       "      <td>Safety and Efficacy of RCT-01 in Men and Women...</td>\n",
       "      <td>no reason</td>\n",
       "      <td>...</td>\n",
       "      <td>not_provided</td>\n",
       "      <td>8</td>\n",
       "      <td>8</td>\n",
       "      <td>VLOW</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>18</td>\n",
       "      <td>Youth</td>\n",
       "      <td>65 Years</td>\n",
       "      <td>stopped</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT02632279</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Not_Provided</td>\n",
       "      <td>44515</td>\n",
       "      <td>44517</td>\n",
       "      <td>FALSE</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>Tryptophan Depletion in Parkinson's Disease Pa...</td>\n",
       "      <td>Tryptophan Depletion in PD Patients Treated Wi...</td>\n",
       "      <td>no reason</td>\n",
       "      <td>...</td>\n",
       "      <td>Deep Brain Stimulation$$Parkinson's disease$$S...</td>\n",
       "      <td>7</td>\n",
       "      <td>7</td>\n",
       "      <td>VLOW</td>\n",
       "      <td>no_criteria</td>\n",
       "      <td>no_criteria Years</td>\n",
       "      <td>no_criteria</td>\n",
       "      <td>nocriteria</td>\n",
       "      <td>no_criteria</td>\n",
       "      <td>stopped</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT04528927</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>43966</td>\n",
       "      <td>44027</td>\n",
       "      <td>TRUE</td>\n",
       "      <td>Withdrawn</td>\n",
       "      <td>Evaluation of the Efficacy and Safety of Treat...</td>\n",
       "      <td>Evaluation of the Efficacy and Safety of Treat...</td>\n",
       "      <td>no reason</td>\n",
       "      <td>...</td>\n",
       "      <td>not_provided</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>VLOW</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>18</td>\n",
       "      <td>Youth</td>\n",
       "      <td>80 Years</td>\n",
       "      <td>stopped</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT04349228</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>43949</td>\n",
       "      <td>44027</td>\n",
       "      <td>TRUE</td>\n",
       "      <td>Withdrawn</td>\n",
       "      <td>Assessment of the Efficacy and Safety of Hydro...</td>\n",
       "      <td>Assessment of the Efficacy and Safety of (HCQ)...</td>\n",
       "      <td>no reason</td>\n",
       "      <td>...</td>\n",
       "      <td>COVID19$$HCQ$$Healthcare Worker$$Hydroxychloro...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>VLOW</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>18</td>\n",
       "      <td>Youth</td>\n",
       "      <td>65 Years</td>\n",
       "      <td>stopped</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT01315158</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Not_Provided</td>\n",
       "      <td>44207</td>\n",
       "      <td>44391</td>\n",
       "      <td>TRUE</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>Incidence of Sedation Related Complications Wi...</td>\n",
       "      <td>Propofol vs Propofol + Benzo/Opiates in High R...</td>\n",
       "      <td>no reason</td>\n",
       "      <td>...</td>\n",
       "      <td>Body Mass Index$$Obstructive Sleep Apnea</td>\n",
       "      <td>36</td>\n",
       "      <td>36</td>\n",
       "      <td>VLOW</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>18</td>\n",
       "      <td>Youth</td>\n",
       "      <td>no_criteria</td>\n",
       "      <td>stopped</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows Ã— 48 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "        nct_id      study_type            phase start_month_year  \\\n",
       "0  NCT02330146  Interventional  Phase 1/Phase 2            44331   \n",
       "1  NCT02632279  Interventional     Not_Provided            44515   \n",
       "2  NCT04528927  Interventional          Phase 3            43966   \n",
       "3  NCT04349228  Interventional          Phase 3            43949   \n",
       "4  NCT01315158  Interventional     Not_Provided            44207   \n",
       "\n",
       "  primary_completion_month_year has_dmc overall_status  \\\n",
       "0                         44546    TRUE     Terminated   \n",
       "1                         44517   FALSE     Terminated   \n",
       "2                         44027    TRUE      Withdrawn   \n",
       "3                         44027    TRUE      Withdrawn   \n",
       "4                         44391    TRUE     Terminated   \n",
       "\n",
       "                                      official_title  \\\n",
       "0  A Randomized, Double-blind, Placebo-controlled...   \n",
       "1  Tryptophan Depletion in Parkinson's Disease Pa...   \n",
       "2  Evaluation of the Efficacy and Safety of Treat...   \n",
       "3  Assessment of the Efficacy and Safety of Hydro...   \n",
       "4  Incidence of Sedation Related Complications Wi...   \n",
       "\n",
       "                                         brief_title why_stopped  ...  \\\n",
       "0  Safety and Efficacy of RCT-01 in Men and Women...   no reason  ...   \n",
       "1  Tryptophan Depletion in PD Patients Treated Wi...   no reason  ...   \n",
       "2  Evaluation of the Efficacy and Safety of Treat...   no reason  ...   \n",
       "3  Assessment of the Efficacy and Safety of (HCQ)...   no reason  ...   \n",
       "4  Propofol vs Propofol + Benzo/Opiates in High R...   no reason  ...   \n",
       "\n",
       "                                       keywords_name enrollment  \\\n",
       "0                                       not_provided          8   \n",
       "1  Deep Brain Stimulation$$Parkinson's disease$$S...          7   \n",
       "2                                       not_provided          0   \n",
       "3  COVID19$$HCQ$$Healthcare Worker$$Hydroxychloro...          0   \n",
       "4           Body Mass Index$$Obstructive Sleep Apnea         36   \n",
       "\n",
       "  enrollment_index enrollment_bins  minimum_age  minimum_age_years  \\\n",
       "0                8            VLOW     18 Years           18 Years   \n",
       "1                7            VLOW  no_criteria  no_criteria Years   \n",
       "2                0            VLOW     18 Years           18 Years   \n",
       "3                0            VLOW     18 Years           18 Years   \n",
       "4               36            VLOW     18 Years           18 Years   \n",
       "\n",
       "  minimum_age_int minimum_age_bins  maximum_age  stopped  \n",
       "0              18            Youth     65 Years  stopped  \n",
       "1     no_criteria       nocriteria  no_criteria  stopped  \n",
       "2              18            Youth     80 Years  stopped  \n",
       "3              18            Youth     65 Years  stopped  \n",
       "4              18            Youth  no_criteria  stopped  \n",
       "\n",
       "[5 rows x 48 columns]"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dataset  = pd.read_csv('why_stopped.csv', sep=',', error_bad_lines=False, index_col=False, dtype='unicode')\n",
    "dataset.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "Int64Index: 13019 entries, 0 to 13018\n",
      "Data columns (total 48 columns):\n",
      " #   Column                         Non-Null Count  Dtype \n",
      "---  ------                         --------------  ----- \n",
      " 0   nct_id                         13019 non-null  object\n",
      " 1   study_type                     13019 non-null  object\n",
      " 2   phase                          13019 non-null  object\n",
      " 3   start_month_year               13019 non-null  object\n",
      " 4   primary_completion_month_year  13019 non-null  object\n",
      " 5   has_dmc                        13019 non-null  object\n",
      " 6   overall_status                 13019 non-null  object\n",
      " 7   official_title                 13019 non-null  object\n",
      " 8   brief_title                    13019 non-null  object\n",
      " 9   why_stopped                    13019 non-null  object\n",
      " 10  enrollment_type                13019 non-null  object\n",
      " 11  study_first_submitted_date     13019 non-null  object\n",
      " 12  results_first_posted_date      13019 non-null  object\n",
      " 13  number_of_facilities           13019 non-null  object\n",
      " 14  number_of_arms                 13019 non-null  object\n",
      " 15  number_of_groups               13019 non-null  object\n",
      " 16  country_name                   13019 non-null  object\n",
      " 17  condition_name                 13019 non-null  object\n",
      " 18  actual_duration                13019 non-null  object\n",
      " 19  were_results_reported          13019 non-null  object\n",
      " 20  has_single_facility            13019 non-null  object\n",
      " 21  allocation                     13019 non-null  object\n",
      " 22  masking                        13019 non-null  object\n",
      " 23  intervention_model             13019 non-null  object\n",
      " 24  primary_purpose                13019 non-null  object\n",
      " 25  observational_model            13019 non-null  object\n",
      " 26  gender                         13019 non-null  object\n",
      " 27  healthy_volunteers             13019 non-null  object\n",
      " 28  population                     13019 non-null  object\n",
      " 29  sampling_method                13019 non-null  object\n",
      " 30  gender_based                   13019 non-null  object\n",
      " 31  intervention_type              13019 non-null  object\n",
      " 32  lead_Sponsor                   13019 non-null  object\n",
      " 33  Agency_Class_Lead              13019 non-null  object\n",
      " 34  lead_or_collaborator           13019 non-null  object\n",
      " 35  subjects_affected              13019 non-null  object\n",
      " 36  subjects_at_risk               13019 non-null  object\n",
      " 37  responsible_party_type         13019 non-null  object\n",
      " 38  keywords_name                  13019 non-null  object\n",
      " 39  enrollment                     13019 non-null  object\n",
      " 40  enrollment_index               13019 non-null  object\n",
      " 41  enrollment_bins                13019 non-null  object\n",
      " 42  minimum_age                    13019 non-null  object\n",
      " 43  minimum_age_years              13019 non-null  object\n",
      " 44  minimum_age_int                13019 non-null  object\n",
      " 45  minimum_age_bins               13019 non-null  object\n",
      " 46  maximum_age                    13019 non-null  object\n",
      " 47  stopped                        13019 non-null  object\n",
      "dtypes: object(48)\n",
      "memory usage: 4.9+ MB\n"
     ]
    }
   ],
   "source": [
    "dataset.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [],
   "source": [
    "all_words=[]\n",
    "stop_words=stopwords.words('english')\n",
    "for sent in dataset['why_stopped'].str.lower():\n",
    "    if type(sent)!=float:\n",
    "        for word in word_tokenize(sent):\n",
    "            if word not in stop_words:\n",
    "                all_words.append(word)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [],
   "source": [
    "dist=FreqDist(all_words)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    },
    {
     "data": {
      "text/plain": [
       "<AxesSubplot:xlabel='Samples', ylabel='Counts'>"
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dist.plot(100)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [],
   "source": [
    "lis=[]\n",
    "for sent in  dataset['why_stopped'].str.lower():\n",
    "    if type(sent)!=float:\n",
    "        lis.append(sent)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [],
   "source": [
    "n_grams=[]\n",
    "words=[]\n",
    "for sent in lis:\n",
    "    for word in sent.lower().split():\n",
    "        if word not in stop_words:\n",
    "            words.append(word)\n",
    "for tup in ngrams(words,2):\n",
    "        n_grams.append(tup)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [],
   "source": [
    "n_grams_dist=FreqDist(n_grams)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [],
   "source": [
    "word_pos=[]\n",
    "for sent in lis:\n",
    "    pl=pos_tag(sent.split())\n",
    "    for index in range(len(pl)):\n",
    "        if pl[index][1]=='JJ':\n",
    "            if index<len(pl)-1:\n",
    "                word_pos.append(pl[index][0]+' '+pl[index+1][0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [],
   "source": [
    "n_grams_dist_jj=FreqDist(word_pos)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('due to', 1932),\n",
       " ('unable to', 295),\n",
       " ('slow accrual', 284),\n",
       " ('low accrual', 216),\n",
       " ('low enrollment', 159),\n",
       " ('interim analysis', 147),\n",
       " ('poor accrual', 137),\n",
       " ('slow recruitment', 116),\n",
       " ('low recruitment', 114),\n",
       " ('slow enrollment', 114),\n",
       " ('principal investigator', 99),\n",
       " ('detailed description.', 95),\n",
       " ('poor recruitment', 84),\n",
       " ('covid-19 pandemic', 82),\n",
       " ('poor enrollment', 82),\n",
       " ('able to', 67),\n",
       " ('insufficient recruitment', 57),\n",
       " ('insufficient enrollment', 54),\n",
       " ('detailed description', 48),\n",
       " ('enough patients', 47),\n",
       " ('primary endpoint', 46),\n",
       " ('difficult to', 46),\n",
       " ('eligible patients', 43),\n",
       " ('accrual rate', 42),\n",
       " ('covid-19 pandemic.', 38),\n",
       " ('slow accrual.', 36),\n",
       " ('early termination', 36),\n",
       " ('low enrollment.', 34),\n",
       " ('administrative reasons', 33),\n",
       " ('clinical trial', 33),\n",
       " ('accrual and', 32),\n",
       " ('low accrual.', 30),\n",
       " ('study drug', 30),\n",
       " ('financial support', 29),\n",
       " ('clinical development', 29),\n",
       " ('insufficient accrual', 29),\n",
       " ('adverse events', 28),\n",
       " ('patient population', 27),\n",
       " ('poor accrual.', 26),\n",
       " ('patient enrollment', 24),\n",
       " ('new study', 23),\n",
       " ('patient recruitment', 22),\n",
       " ('poor patient', 21),\n",
       " ('subject recruitment', 21),\n",
       " ('sufficient number', 20),\n",
       " ('clinical hold', 20),\n",
       " ('inadequate recruitment', 20),\n",
       " ('inadequate enrollment', 20),\n",
       " ('possible to', 19),\n",
       " ('covid-19 and', 19),\n",
       " ('strategic decision', 19),\n",
       " ('new protocol', 18),\n",
       " ('low patient', 18),\n",
       " ('primary investigator', 18),\n",
       " ('enough participants', 17),\n",
       " ('eligible subjects', 17),\n",
       " ('interim analysis.', 17),\n",
       " ('early due', 17),\n",
       " ('low rate', 16),\n",
       " ('available for', 16),\n",
       " ('poor enrollment.', 16),\n",
       " ('administrative reasons.', 15),\n",
       " ('unlikely to', 15),\n",
       " ('clinical study', 15),\n",
       " ('poor recruitment.', 15),\n",
       " ('insufficient patient', 15),\n",
       " ('insufficient number', 15),\n",
       " ('pharmaceutical company', 14),\n",
       " ('slow patient', 14),\n",
       " ('primary objective', 14),\n",
       " ('subject enrollment', 14),\n",
       " ('insufficient efficacy', 14),\n",
       " ('impossible to', 13),\n",
       " ('low recruitment.', 13),\n",
       " ('unrelated to', 13),\n",
       " ('available to', 13),\n",
       " ('strategic considerations', 13),\n",
       " ('other studies', 13),\n",
       " ('feasible to', 12),\n",
       " ('few patients', 12),\n",
       " ('adverse event', 12),\n",
       " ('other -', 12),\n",
       " ('serious adverse', 11),\n",
       " ('adequate number', 11),\n",
       " ('similar study', 11),\n",
       " ('primary endpoint.', 11),\n",
       " ('accrual goal', 11),\n",
       " ('primary efficacy', 11),\n",
       " ('slow inclusion', 11),\n",
       " ('low inclusion', 11),\n",
       " ('sample size', 10),\n",
       " ('technical issues', 10),\n",
       " ('patient accrual', 10),\n",
       " ('primary outcome', 10),\n",
       " ('technical problems', 10),\n",
       " ('interim data', 10),\n",
       " ('insufficient resources', 10),\n",
       " ('prematurely, prior', 9),\n",
       " ('enough subjects', 9),\n",
       " ('corporate decision', 9)]"
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "n_grams_dist_jj.most_common(100)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [],
   "source": [
    "word_pos_3=[]\n",
    "for sent in lis:\n",
    "    words_nostop=[]\n",
    "    for word in sent.split():\n",
    "        if word not in stop_words:\n",
    "             words_nostop.append(word)\n",
    "    pl=pos_tag(words_nostop)\n",
    "    for index in range(len(pl)):\n",
    "        if pl[index][1]=='JJ':\n",
    "            if index<len(pl)-2:\n",
    "                word_pos_3.append(pl[index][0]+' '+pl[index+1][0]+' '+pl[index+2][0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('due slow accrual', 46),\n",
       " ('principal investigator left', 46),\n",
       " ('due low enrollment', 33),\n",
       " ('due poor accrual', 32),\n",
       " ('due covid-19 pandemic', 32),\n",
       " ('due lack efficacy', 31),\n",
       " ('low recruitment rate', 30),\n",
       " ('due slow recruitment', 29),\n",
       " ('due slow enrollment', 28),\n",
       " ('due lack funding', 28),\n",
       " ('due slow accrual.', 27),\n",
       " ('due low accrual', 26),\n",
       " ('due covid-19 pandemic.', 25),\n",
       " ('interim analysis showed', 25),\n",
       " ('due low enrollment.', 22),\n",
       " ('low accrual rate', 21),\n",
       " ('due poor accrual.', 20),\n",
       " ('detailed description termination', 18),\n",
       " ('due lack efficacy.', 16),\n",
       " ('due lack accrual', 15),\n",
       " ('due lack funding.', 15),\n",
       " ('due safety concerns.', 15),\n",
       " ('early termination due', 15),\n",
       " ('due low recruitment', 14),\n",
       " ('due slow enrollment.', 14),\n",
       " ('resume; participants longer', 13),\n",
       " ('due covid-19 expected', 13),\n",
       " ('unable recruit patients', 12),\n",
       " ('early due lack', 12),\n",
       " ('due low accrual.', 12),\n",
       " ('early due slow', 12),\n",
       " ('slow recruitment rate', 12),\n",
       " ('prematurely, prior enrollment', 10),\n",
       " ('due lack eligible', 10),\n",
       " ('unable recruit enough', 10),\n",
       " ('due slow recruitment.', 10),\n",
       " ('low enrollment rate', 10),\n",
       " ('unable recruit sufficient', 9),\n",
       " ('unable recruit participants', 9),\n",
       " ('unable enroll patients', 9),\n",
       " ('due lack enrollment.', 9),\n",
       " ('due poor enrollment', 9),\n",
       " ('due covid-19 pandemic,', 9),\n",
       " ('due safety concerns', 9),\n",
       " ('light demands certain', 9),\n",
       " ('certain national health', 9),\n",
       " ('national health authorities', 9),\n",
       " ('due poor recruitment', 8),\n",
       " ('due lack enrollment', 8),\n",
       " ('sufficient number patients', 8),\n",
       " ('unable recruit subjects', 8),\n",
       " ('due business decision', 8),\n",
       " ('due poor enrollment.', 8),\n",
       " ('due low recruitment.', 8),\n",
       " ('principal investigator decided', 8),\n",
       " ('low inclusion rate', 8),\n",
       " ('due lack resources', 7),\n",
       " ('due inability recruit', 7),\n",
       " ('serious adverse events', 7),\n",
       " ('unable recruit adequate', 7),\n",
       " ('due business reasons.', 7),\n",
       " ('due poor recruitment.', 7),\n",
       " ('early due low', 7),\n",
       " ('due administrative reasons', 7),\n",
       " ('primary efficacy endpoint', 7),\n",
       " ('accrual goal met', 7),\n",
       " ('interim analysis indicated', 7),\n",
       " ('due funding issues', 6),\n",
       " ('unable enroll subjects', 6),\n",
       " ('strategic business decision', 6),\n",
       " ('due lack recruitment.', 6),\n",
       " ('due safety concerns,', 6),\n",
       " ('due poor patient', 6),\n",
       " ('new efficacy data', 6),\n",
       " ('interim analysis suggested', 6),\n",
       " ('poor patient accrual', 6),\n",
       " ('low patient accrual', 6),\n",
       " ('inadequate accrual rate', 6),\n",
       " ('resume future. suspension', 6),\n",
       " ('future. suspension irb', 6),\n",
       " ('due change standard', 5),\n",
       " ('unable obtain funding', 5),\n",
       " ('unable enroll participants', 5),\n",
       " ('slow patient recruitment', 5),\n",
       " ('low enrollment due', 5),\n",
       " ('due safety efficacy', 5),\n",
       " ('low patient enrollment', 5),\n",
       " ('early due poor', 5),\n",
       " ('insufficient patient recruitment.', 5),\n",
       " ('early due business', 5),\n",
       " ('due insufficient efficacy', 5),\n",
       " ('original principal investigator', 5),\n",
       " ('due slow patient', 5),\n",
       " ('slow patient accrual', 5),\n",
       " ('due lack recruitment', 5),\n",
       " ('due business reasons', 5),\n",
       " ('early termination study', 5),\n",
       " ('primary endpoint met', 5),\n",
       " ('due covid 19', 5),\n",
       " ('strategic decision unrelated', 5),\n",
       " ('unrelated safety efficacy', 5),\n",
       " ('primary investigator left', 5),\n",
       " ('poor patient recruitment', 5),\n",
       " ('eligible patient enrolled.', 5),\n",
       " ('negative efficacy results', 5),\n",
       " ('difficult recruit participants', 5),\n",
       " ('interim analysis revealed', 5),\n",
       " ('interim analysis results', 5),\n",
       " ('insufficient recruitment rate', 5),\n",
       " ('insufficient number participants', 5),\n",
       " ('solar study idmc,', 5),\n",
       " ('az decision discontinue', 5),\n",
       " ('patient enrollment treatment.', 4),\n",
       " ('clinical trial facility', 4),\n",
       " ('due viral limitations', 4),\n",
       " ('viral limitations loss', 4),\n",
       " ('low rate recruitment', 4),\n",
       " ('unique provision american', 4),\n",
       " ('american recovery reinvestment', 4),\n",
       " ('second year no-cost-extension', 4),\n",
       " ('unable recruit due', 4),\n",
       " ('adequate number patients', 4),\n",
       " ('unable meet enrollment', 4),\n",
       " ('unable enroll enough', 4),\n",
       " ('complete enrollment due', 4),\n",
       " ('early per business', 4),\n",
       " ('due company decision', 4),\n",
       " ('due insufficient recruitment.', 4),\n",
       " ('due slow enrollment,', 4),\n",
       " ('due interim analysis', 4),\n",
       " ('due lack study', 4),\n",
       " ('serious adverse event', 4),\n",
       " ('early due difficulties', 4),\n",
       " ('due enrollment challenges', 4),\n",
       " ('due difficulty recruiting', 4),\n",
       " ('european medicines agency', 4),\n",
       " ('principal investigator moved', 4),\n",
       " ('pre-planned interim analysis', 4),\n",
       " ('due non-safety related', 4),\n",
       " ('enable registration duvelisib.', 4),\n",
       " ('close study due', 4),\n",
       " ('overall profile support', 4),\n",
       " ('profile support development', 4),\n",
       " ('independent data monitoring', 4),\n",
       " ('overall schizophrenia participant', 4),\n",
       " ('schizophrenia participant population.', 4),\n",
       " ('due acquisition peak', 4),\n",
       " ('due insufficient efficacy.', 4),\n",
       " ('due lack clinical', 4),\n",
       " ('due study design', 4),\n",
       " ('due sponsor decision', 4),\n",
       " ('due lack accrual.', 4),\n",
       " ('due lack feasibility', 4),\n",
       " ('high screen fail', 4),\n",
       " ('slow accrual rate', 4),\n",
       " ('study-related data unavailable.', 4),\n",
       " ('issue: trial prematurely', 4),\n",
       " ('dec 9, 2010,', 4),\n",
       " ('new emerging evidence', 4),\n",
       " ('principal investigator leaving', 4),\n",
       " ('primary investigator longer', 4),\n",
       " ('pediatric development program', 4),\n",
       " ('original pi left', 4),\n",
       " ('enough patients meeting', 4),\n",
       " ('low enrolment rate', 4),\n",
       " ('possible recruit desired', 4),\n",
       " ('internal business decision', 4),\n",
       " ('insufficient patient recruitment', 4),\n",
       " ('inadequate patient recruitment', 4),\n",
       " ('idmc recommendation safety', 4),\n",
       " ('former pi left', 4),\n",
       " ('financial assistance financial', 4),\n",
       " ('resume future; suspension', 4),\n",
       " ('future; suspension irb', 4),\n",
       " ('due covid-19. expected', 4),\n",
       " ('due potential concerns', 4),\n",
       " ('potential concerns liver', 4),\n",
       " ('due covid-19 lockdown', 4),\n",
       " ('clinical studies stopped,', 4),\n",
       " ('available data, ucb', 4),\n",
       " ('adjunctive treatment focal-onset', 4),\n",
       " ('due safety reasons.', 3),\n",
       " ('unable recruit suitable', 3),\n",
       " ('able recruit enough', 3),\n",
       " ('receive proper funding', 3),\n",
       " ('sufficient number subjects', 3),\n",
       " ('slow recruitment rate.', 3),\n",
       " ('low rate patient', 3),\n",
       " ('unable recruit study', 3),\n",
       " ('unable recruit patients.', 3),\n",
       " ('adequate number participants', 3),\n",
       " ('unable meet recruitment', 3),\n",
       " ('willing participate study', 3),\n",
       " ('unable find patients', 3),\n",
       " ('unable enroll adequate', 3),\n",
       " ('unable complete study', 3),\n",
       " ('unable begin study', 3),\n",
       " ('prior patient enrollment', 3),\n",
       " ('slow accrual patients.', 3),\n",
       " ('due recruitment difficulties.', 3),\n",
       " ('due administrative reasons.', 3),\n",
       " ('related corporate decision.', 3),\n",
       " ('enough patients recruited', 3),\n",
       " (\"due sponsor's decision\", 3),\n",
       " ('due corporate decision.', 3),\n",
       " ('due change strategy', 3),\n",
       " ('interim analysis performed', 3),\n",
       " ('due difficulty enrollment', 3),\n",
       " ('due difficulties recruiting', 3),\n",
       " ('due slower anticipated', 3),\n",
       " ('due lack patient', 3),\n",
       " ('due insufficient recruitment', 3),\n",
       " ('due recruitment difficulties', 3),\n",
       " ('focus resources studies', 3),\n",
       " ('interim futility analysis', 3),\n",
       " ('nevoÃ¢â€žÂ¢ stent commercialized.', 3),\n",
       " ('insufficient evidence clinical', 3),\n",
       " ('primary endpoint reached.', 3),\n",
       " ('dose limiting toxicity', 3),\n",
       " (\"due sponsor's decision.\", 3),\n",
       " ('due safety concern', 3),\n",
       " ('accrual due competing', 3),\n",
       " ('due inability enroll', 3),\n",
       " ('due sponsor decision.', 3),\n",
       " ('slow accrual, pi', 3),\n",
       " ('due limited enrollment', 3),\n",
       " ('insufficient number subjects', 3),\n",
       " ('due lack available', 3),\n",
       " ('due business decisions.', 3),\n",
       " ('due scientific business', 3),\n",
       " ('scientific business considerations.', 3),\n",
       " ('low enrollment rate.', 3),\n",
       " ('enrolment reasons related', 3),\n",
       " ('related vaccine safety', 3),\n",
       " ('due reproducibility issues', 3),\n",
       " ('due covid-19 restrictions', 3),\n",
       " ('sponsor result business', 3),\n",
       " ('mk-8342b reasons unrelated', 3),\n",
       " ('unrelated safety efficacy.', 3),\n",
       " ('sufficient data collected', 3),\n",
       " ('clinical hold fda', 3),\n",
       " ('interim analysis primary', 3),\n",
       " ('institutional review board', 3),\n",
       " ('likely meet primary', 3),\n",
       " ('due slow inclusion', 3),\n",
       " (\"sponsor's decision pursue\", 3),\n",
       " ('long term clinical', 3),\n",
       " ('clinical data collected', 3),\n",
       " ('study drug relevant', 3),\n",
       " ('due recruitment problems', 3),\n",
       " ('clinical trial development', 3),\n",
       " ('due changes standard', 3),\n",
       " ('slow patient enrollment', 3),\n",
       " ('slow inclusion rate.', 3),\n",
       " ('slow enrollment due', 3),\n",
       " ('slow enrollment lack', 3),\n",
       " ('slow accrual due', 3),\n",
       " ('due revision local', 3),\n",
       " ('principal investigator retired', 3),\n",
       " ('principal investigator longer', 3),\n",
       " ('interim data analysis', 3),\n",
       " ('poor recruitment rate', 3),\n",
       " ('poor enrollment study', 3),\n",
       " ('reasonable time frame.', 3),\n",
       " ('able reached updates', 3),\n",
       " ('due low rate', 3),\n",
       " ('overall profile compound', 3),\n",
       " ('significant clinical advantage', 3),\n",
       " ('clinical advantage patients', 3),\n",
       " ('available lipid lowering', 3),\n",
       " ('lipid lowering agents', 3),\n",
       " ('due covid-19 outbreak', 3),\n",
       " ('enough participants enrolled', 3),\n",
       " ('able recruit participants', 3),\n",
       " ('new data: study', 3),\n",
       " ('clinical development plan', 3),\n",
       " ('low qualified candidate', 3),\n",
       " ('low patient recruitment', 3),\n",
       " ('low accrual due', 3),\n",
       " ('logistic reasons associated', 3),\n",
       " ('fda-imposed clinical hold.', 3),\n",
       " ('interim assessment: lack', 3),\n",
       " ('assessment: lack efficacy', 3),\n",
       " ('significant differences two', 3),\n",
       " ('insufficient enrollment rate', 3),\n",
       " ('insufficient accrual rate', 3),\n",
       " ('hepatic safety signal', 3),\n",
       " ('funding period ended', 3),\n",
       " ('gsk1322322 pre-clinical data', 3),\n",
       " (\"pre-clinical data id'd\", 3),\n",
       " ('reactive metabolites previously', 3),\n",
       " ('risk: benefit profile', 3),\n",
       " ('early termination discouraging', 3),\n",
       " ('long term follow', 3),\n",
       " ('due budget limitations,', 3),\n",
       " ('closed chum reb', 3),\n",
       " ('available treatments, overall', 3),\n",
       " ('overall benefit risk', 3),\n",
       " ('unable submit results-data.', 3),\n",
       " ('due poor/low accrual', 2),\n",
       " ('primary endpoint key', 2),\n",
       " ('key secondary endpoints.', 2),\n",
       " ('sufficient numbers patients', 2),\n",
       " ('suitable patients study', 2),\n",
       " ('able enroll patients.', 2),\n",
       " ('low recruitment rates', 2),\n",
       " ('clinical hold issued', 2),\n",
       " ('low accrual rate.', 2),\n",
       " ('sufficient number participants.', 2),\n",
       " ('high drop-out rate.', 2),\n",
       " ('unable secure funding', 2),\n",
       " ('necessary number patients', 2),\n",
       " ('unable recruit individuals', 2),\n",
       " ('unable recruit enroll', 2),\n",
       " ('adequate number subjects', 2),\n",
       " ('high attrition rate', 2),\n",
       " ('unable find subjects', 2),\n",
       " ('unable find enough', 2),\n",
       " ('enough patients accept', 2),\n",
       " ('randomization surgical procedures.', 2),\n",
       " ('unable enroll sufficient', 2),\n",
       " ('due time constraints', 2),\n",
       " ('unable continue enrollment', 2),\n",
       " ('complete sample size', 2),\n",
       " ('due changes surgical', 2),\n",
       " ('unable accrue subjects.', 2),\n",
       " ('unable accrue patients', 2),\n",
       " ('unable accrue subjects', 2),\n",
       " ('due impact covid-19', 2),\n",
       " ('early due limited', 2),\n",
       " ('first patient first', 2),\n",
       " ('(no patient enrolled)', 2),\n",
       " ('adverse events observed', 2),\n",
       " ('777-clp-029 meet superiority', 2),\n",
       " ('due high screen', 2),\n",
       " ('main study results', 2),\n",
       " ('due low patient', 2),\n",
       " ('early due recruitment', 2),\n",
       " ('clinical study protocol.', 2),\n",
       " ('early due administrative', 2),\n",
       " ('early result regulatory', 2),\n",
       " ('regulatory action suspending', 2),\n",
       " ('planned sample size', 2),\n",
       " ('due insufficient subject', 2),\n",
       " ('slow enrollment enrolling', 2),\n",
       " ('due strategic considerations', 2),\n",
       " ('receive irb approval', 2),\n",
       " ('slow enrollment, safety', 2),\n",
       " ('consistent current clinical', 2),\n",
       " ('slow recruitment study', 2),\n",
       " ('long-term follow-up would', 2),\n",
       " ('high drop-out rate', 2),\n",
       " ('enough patients enrolled.', 2),\n",
       " ('slow accrual rate.', 2),\n",
       " ('due sars-cov-2 pandemic.', 2),\n",
       " ('able recruit subjects.', 2),\n",
       " ('due change study', 2),\n",
       " ('due long period', 2),\n",
       " ('sufficient amount data', 2),\n",
       " ('scientific objectives met', 2),\n",
       " ('due commercial availability', 2),\n",
       " ('enough funding complete', 2),\n",
       " ('pf-03084014 development. safety/efficacy', 2),\n",
       " ('interim analysis futility', 2),\n",
       " ('logistic reasons related', 2),\n",
       " ('due poor subject', 2),\n",
       " ('early due difficulty', 2),\n",
       " ('clinical study drug', 2),\n",
       " ('slow accrual subjects.', 2),\n",
       " ('due results another', 2),\n",
       " ('due recruitment challenges', 2),\n",
       " ('due challenges recruiting', 2),\n",
       " ('due small number', 2),\n",
       " ('due change sponsor', 2),\n",
       " ('major safety tolerability', 2),\n",
       " ('related studies ruxolitinib', 2),\n",
       " ('sufficient efficacy warrant', 2),\n",
       " ('due logistical issues', 2),\n",
       " ('due patient enrollment', 2),\n",
       " ('due insufficient accrual', 2),\n",
       " ('due failure recruit', 2),\n",
       " ('interim analysis due', 2),\n",
       " ('due recruitment issues', 2),\n",
       " ('first interim analysis', 2),\n",
       " ('due competing trials', 2),\n",
       " ('due investigator discretion', 2),\n",
       " ('perceived clinical activity', 2),\n",
       " ('clinical activity observed', 2),\n",
       " ('prior enrollment participants.', 2),\n",
       " ('due budget limitations', 2),\n",
       " ('due lack funds.', 2),\n",
       " ('able start study', 2),\n",
       " ('due administrative reasons,', 2),\n",
       " ('high number protocol', 2),\n",
       " ('early result coronavirus', 2),\n",
       " ('primary secondary efficacy', 2),\n",
       " ('first phase meet', 2),\n",
       " ('poor accrual difficulty', 2),\n",
       " ('due gmp deficiencies', 2),\n",
       " ('fda inspection site', 2),\n",
       " ('sample size re-calculated', 2),\n",
       " ('re-calculated based first', 2),\n",
       " ('outweigh benefits participants', 2),\n",
       " ('allergic asthma due', 2),\n",
       " ('institute, rest investigators', 2),\n",
       " ('decided terminate study.', 2),\n",
       " ('risk-benefit ratio individuals', 2),\n",
       " ('close study 3', 2),\n",
       " ('main investigators longer', 2),\n",
       " ('accrual rate study', 2),\n",
       " ('interim analysis shown', 2),\n",
       " ('nct00910091 patients endometrial', 2),\n",
       " ('endometrial cancer shows', 2),\n",
       " ('possible health risk', 2),\n",
       " ('lorcaserin drug withdrawn.', 2),\n",
       " ('new study design', 2),\n",
       " ('entire drug development', 2),\n",
       " ('end inclusion period', 2),\n",
       " ('ec withdrawn approval', 2),\n",
       " ('possible conflicts interests', 2),\n",
       " ('primary efficacy endpoint.', 2),\n",
       " (\"due company's strategy\", 2),\n",
       " ('slow rate recruitment', 2),\n",
       " ('covid-19 pandemic impacted', 2),\n",
       " ('clinical phase study', 2),\n",
       " ('fsfv lslv) never', 2),\n",
       " ('financial support withdrawn', 2),\n",
       " ('sufficient warrant development', 2),\n",
       " ('interim analysis found', 2),\n",
       " ('termination: lack efficacy', 2),\n",
       " ('due indication change.', 2),\n",
       " ('due competing studies.', 2),\n",
       " ('adverse event issues.', 2),\n",
       " ('primary secondary outcome', 2),\n",
       " ('early due funding', 2),\n",
       " ('administrative reasons unrelated', 2),\n",
       " ('due safety concerns).', 2),\n",
       " ('due slow accrual,', 2),\n",
       " ('due delay site', 2),\n",
       " ('due distribution issue', 2),\n",
       " ('temporary halt due', 2),\n",
       " ('due adverse events', 2),\n",
       " ('due covid19 pandemic', 2),\n",
       " ('due covid-19 resume', 2),\n",
       " ('public health authorities.', 2),\n",
       " ('technical problems equipment', 2),\n",
       " ('due change development', 2),\n",
       " ('due slow recruitment,', 2),\n",
       " ('nci - see', 2),\n",
       " ('sufficient evidence efficacy', 2),\n",
       " ('strict inclusion criteria', 2),\n",
       " ('early business reasons', 2),\n",
       " ('due lack interest', 2),\n",
       " ('due funding issues.', 2),\n",
       " ('due cardiac toxicities', 2),\n",
       " ('cardiac toxicities subjects', 2),\n",
       " ('patient safety concerns', 2),\n",
       " ('due difficulty finding', 2),\n",
       " ('low enrollment lack', 2),\n",
       " ('due inability accrue', 2),\n",
       " ('due administrative reason', 2),\n",
       " ('due lack participants', 2),\n",
       " ('new study written', 2),\n",
       " ('financial reasons covid-19', 2),\n",
       " ('due strategic business', 2),\n",
       " ('poor patient recruitment.', 2),\n",
       " ('patient population available', 2),\n",
       " ('due low probability', 2),\n",
       " ('low probability achieving', 2),\n",
       " ('due change benefit-risk', 2),\n",
       " ('due unfavorable risk-benefit', 2),\n",
       " ('adverse events related', 2),\n",
       " ('slow accrual lack', 2),\n",
       " ('due covid-19 restrictions.', 2),\n",
       " ('covid-19 - vaccinations', 2),\n",
       " ('clinical development program', 2),\n",
       " ('due company strategic', 2),\n",
       " ('due business reasons,', 2),\n",
       " ('due competing trial.', 2),\n",
       " ('due difficulty enrolling', 2),\n",
       " ('feasible due slow', 2),\n",
       " (\"new posting sponsor's\", 2),\n",
       " ('due unavailability eligible', 2),\n",
       " ('eligible subject population.', 2),\n",
       " ('subject population. request', 2),\n",
       " ('mi-cp198 per cpm.', 2),\n",
       " ('able meet target', 2),\n",
       " ('new protocol number', 2),\n",
       " ('due clinical hold.', 2),\n",
       " ('enrollment first participant.', 2),\n",
       " ('due difficulties recruitment', 2),\n",
       " ('enrollment first patient', 2),\n",
       " ('low enrollment pi', 2),\n",
       " ('study drug supply', 2),\n",
       " ('study drug became', 2),\n",
       " ('study start due', 2),\n",
       " ('primary endpoint. linked', 2),\n",
       " ('due change clinical', 2),\n",
       " ('insufficient sample size', 2),\n",
       " ('recruitment rate slow', 2),\n",
       " ('strategic reasons company', 2),\n",
       " ('principal investigator decision', 2),\n",
       " ('stop drug development', 2),\n",
       " ('slow inclusion rate', 2),\n",
       " ('statistical analysis interim', 2),\n",
       " ('interim analysis determined', 2),\n",
       " ('standard care changed', 2),\n",
       " ('sponsor/ pi leaving', 2),\n",
       " ('institution, plans continue', 2),\n",
       " ('ms disease activity', 2),\n",
       " ('enable registration duvelisib', 2),\n",
       " ('different endpoint replace', 2),\n",
       " ('meet primary endpoint.', 2),\n",
       " ('due low subject', 2),\n",
       " ('low enrollment sponsor', 2),\n",
       " ('primary endpoint study', 2),\n",
       " ('slow, insufficient accrual.', 2),\n",
       " ('slow recruitment. safety', 2),\n",
       " ('slow recruitment subjects', 2),\n",
       " ('slow recruitment eligible', 2),\n",
       " ('slow recruitment due', 2),\n",
       " ('slow recruitment high', 2),\n",
       " ('slow enrollment, study', 2),\n",
       " ('slow accrual, study', 2),\n",
       " ('slow accrual led', 2),\n",
       " ('early study termination.', 2),\n",
       " ('several factors contributed', 2),\n",
       " ('significant challenges enrollment', 2),\n",
       " ('visual difference affected', 2),\n",
       " ('sotagliflozin. china regulatory', 2),\n",
       " ('regulatory pathway transfer', 2),\n",
       " ('former qualified investigator', 2),\n",
       " ('interim analysis conducted', 2),\n",
       " ('regulatory approval obtained', 2),\n",
       " ('drisapersen, hence biomarin', 2),\n",
       " ('insufficient number patients', 2),\n",
       " ('slow recruitment. linked', 2),\n",
       " ('organizational changes made', 2),\n",
       " ('financial support study', 2),\n",
       " ('conclusive proof worthwhile', 2),\n",
       " ('re-done collaboration cms', 2),\n",
       " ('low recruitment cohort', 2),\n",
       " ('project end 3', 2),\n",
       " ('unable fulfill responsibilities.', 2),\n",
       " ('principal investigator sponsor', 2),\n",
       " ('principal investigator (dr.', 2),\n",
       " ('primary investigator resigned', 2),\n",
       " ('primary endpoint (safety)', 2),\n",
       " ('pre-specified interim analysis', 2),\n",
       " ('due insufficient patient', 2),\n",
       " ('preliminary results showed', 2),\n",
       " ('poor recruitment due', 2),\n",
       " ('due change surgical', 2),\n",
       " ('poor patient recruitment,', 2),\n",
       " ('poor patient enrollment', 2),\n",
       " ('poor enrollment; pi', 2),\n",
       " ('poor case accrual', 2),\n",
       " ('poor accrual rate', 2),\n",
       " ('poor accrual eligible', 2),\n",
       " ('accrual eligible patients', 2),\n",
       " ('poor accrual change', 2),\n",
       " ('due personal family', 2),\n",
       " ('personal family health', 2),\n",
       " ('funding. study terminated', 2),\n",
       " ('pi job change', 2),\n",
       " ('due technical issues', 2),\n",
       " ('slow patient accrual.', 2),\n",
       " ('irb covid-19 guidance', 2),\n",
       " ('covid-19 guidance conducting', 2),\n",
       " ('human subjects research', 2),\n",
       " ('patient recruitment difficulties', 2),\n",
       " ('maximum tolerated dose', 2),\n",
       " ('overall response rate', 2),\n",
       " ('overall clinical activity', 2),\n",
       " ('clinical activity (orr)', 2),\n",
       " ('minimal across tumor', 2),\n",
       " ('original investigator left', 2),\n",
       " ('ofatumumab iv trials', 2),\n",
       " ('clinical development autoimmune', 2),\n",
       " ('opv116910 opv117059 studies.', 2),\n",
       " ('due requirement regulatory', 2),\n",
       " ('regulatory authorities additional', 2),\n",
       " ('additional data secure', 2),\n",
       " ('feasible recruit follow-up', 2),\n",
       " ('follow-up subjects due', 2),\n",
       " ('enough patients included', 2),\n",
       " ('eligible patients available', 2),\n",
       " ('due safety due', 2),\n",
       " ('able recruit patients', 2),\n",
       " ('nonapplicable clinical trial', 2),\n",
       " ('applicable clinical trial', 2),\n",
       " ('due enrollment challenges.', 2),\n",
       " ('eligible patients could', 2),\n",
       " ('enrolled patients received', 2),\n",
       " ('new data; study', 2),\n",
       " ('myriad discontinued development', 2),\n",
       " ('potential contamination one', 2),\n",
       " ('clinical development atopic', 2),\n",
       " ('microbiological findings resistance', 2),\n",
       " ('urinary tract infection', 2),\n",
       " ('melagatran/ximelagatran withdrawn market', 2),\n",
       " ('clinical development february', 2),\n",
       " ('february 2006 interest', 2),\n",
       " ('pharmaceutical company due', 2),\n",
       " ('due strict inclusion', 2),\n",
       " ('major inclusion difficulties', 2),\n",
       " ('major difficulties recruiting', 2),\n",
       " ('low study accrual', 2),\n",
       " ('low recruitment rate;', 2),\n",
       " ('reasonable time frame', 2),\n",
       " ('low recruitment rate,', 2),\n",
       " ('low recruitment numbers', 2),\n",
       " ('low recruitment due', 2),\n",
       " ('low recruitement rate', 2),\n",
       " ('low rate enrollment', 2),\n",
       " ('low number patients', 2),\n",
       " ('low levels recruitment', 2),\n",
       " ('low enrollment numbers', 2),\n",
       " ('reasonable amount time.', 2),\n",
       " ('low accrual, funding', 2),\n",
       " ('low accrual allowing', 2),\n",
       " ('insufficient funds complete', 2),\n",
       " ('logistical challenges; safety', 2),\n",
       " ('lead investigator moved', 2),\n",
       " ('new medical center;', 2),\n",
       " ('medical center; study', 2),\n",
       " ('large sample size', 2),\n",
       " ('available complete study.', 2),\n",
       " ('lack drug supply', 2),\n",
       " ('difficult enroll patients', 2),\n",
       " ('january 2014 terminate', 2),\n",
       " ('early primary efficacy', 2),\n",
       " ('endpoint part decision', 2),\n",
       " ('clinical study snn0031-004.', 2),\n",
       " ('favorable benefit risk', 2),\n",
       " ('available sufficient quantity', 2),\n",
       " ('institution. data analysis', 2),\n",
       " ('ace-083 use patients', 2),\n",
       " ('functional secondary endpoints', 2),\n",
       " ('secondary endpoints a083-03', 2),\n",
       " ('interim results suggested', 2),\n",
       " ('interim analysis shows', 2),\n",
       " ('interim analysis efficacy', 2),\n",
       " ('interim analysis data', 2),\n",
       " ('insufficient resources available', 2),\n",
       " ('available complete study', 2),\n",
       " ('insufficient patient participation', 2),\n",
       " ('insufficient patient enrollment', 2),\n",
       " ('insufficient on-site staff', 2),\n",
       " ('on-site staff manage', 2),\n",
       " ('insufficient funding available', 2),\n",
       " ('insufficient findings data', 2),\n",
       " ('clinical effectiveness cangrelor', 2),\n",
       " ('insufficient efficacy observed', 2),\n",
       " ('inadequate enrollment rate', 2),\n",
       " ('additional safety data', 2),\n",
       " ('due insufficient level', 2),\n",
       " ('insufficient level efficacy', 2),\n",
       " ('hiv-infected patients number', 2),\n",
       " ('exact causality could', 2),\n",
       " ('human subjects protection', 2),\n",
       " ('covid-19 pandemic prevented', 2),\n",
       " ('due low inclusion', 2),\n",
       " ('unrelated safety tolerability,tonix', 2),\n",
       " ('fibromyalgia development tnx102', 2),\n",
       " ('full clinical hold', 2),\n",
       " ('due difficulties enrolling', 2),\n",
       " ('failed meet enrollment', 2),\n",
       " ('chloroquine effective covid-19', 2),\n",
       " ('low probability success.', 2),\n",
       " ('potential amendments study', 2),\n",
       " ('reopen future. suspension', 2),\n",
       " ('allotted recruitment period', 2),\n",
       " ('due changes standards', 2),\n",
       " ('enrollment trial activities', 2),\n",
       " ('due inability meet', 2),\n",
       " ('early end enrolment', 2),\n",
       " ('slow recruitment patients', 2),\n",
       " ('due delay study', 2),\n",
       " ('covid-19 pandemic, unable', 2),\n",
       " ('poor accrual study', 2),\n",
       " ('due overall benefit/risk', 2),\n",
       " ('overall benefit/risk profile', 2),\n",
       " ('due robust long-term', 2),\n",
       " ('robust long-term data', 2),\n",
       " ('long-term data generated', 2),\n",
       " ('due lack availability', 2),\n",
       " ('due financial reasons', 2),\n",
       " ('due fda comments,', 2),\n",
       " ('due end validity', 2),\n",
       " ('covid-19 safety precautions', 2),\n",
       " ('due covid-19 research', 2),\n",
       " ('covid-19 research activities', 2),\n",
       " ('difficult recruit patients', 2),\n",
       " ('due covid-19 policies.', 2),\n",
       " ('incomplete documentation research', 2),\n",
       " ('clinical hold safety', 2),\n",
       " ('clinical benefit noted', 2),\n",
       " ('departmental staff led', 2),\n",
       " ('celgene-sponsored trials mgcd0103', 2),\n",
       " ('preliminary parent study', 2),\n",
       " ('unrelated safety concerns.', 2),\n",
       " ('bad recruitment suitable', 2),\n",
       " ('senior lost interest', 2),\n",
       " ('new promising therapeutic', 2),\n",
       " ('promising therapeutic agents', 2),\n",
       " ('therapeutic agents expected', 2),\n",
       " ('animal safety data', 2),\n",
       " ('independent assessment concluded', 2),\n",
       " ('primary endpoint upon', 2),\n",
       " ('amg102 clinical studies', 2),\n",
       " ('clinical studies terminated', 2),\n",
       " ('pre-planned data monitoring', 2),\n",
       " ('adverse change risk/benefit', 2),\n",
       " ('accrual issues -', 2),\n",
       " ('pharmacokinetic (pk) characteristics', 2),\n",
       " ('oprozomib studies required', 2),\n",
       " ('accrual failure generate', 1),\n",
       " ('supply drug study', 1),\n",
       " ('accurate information patients', 1),\n",
       " ('withdrawn-was approved irb', 1),\n",
       " ('unable set appropriate', 1),\n",
       " ('appropriate infrastructure support', 1),\n",
       " ('participant enrollment due', 1),\n",
       " ('due funding status', 1),\n",
       " ('due protocol amendment', 1),\n",
       " ('due poor accrual/lack', 1),\n",
       " ('poor accrual/lack funding', 1),\n",
       " ('due medication withdrawal', 1),\n",
       " ('due lack participants.', 1),\n",
       " ('accrual per center', 1),\n",
       " ('due contractual issues', 1),\n",
       " ('new protocol required', 1),\n",
       " ('due change plan', 1),\n",
       " ('due excess toxic', 1),\n",
       " ('excess toxic deaths', 1),\n",
       " ('due \"toxicity\" problems', 1),\n",
       " ('dramatic changes main', 1),\n",
       " ('main endpoint, well', 1),\n",
       " ('low enrollment numbers.', 1),\n",
       " ('interpretable terms efficacy.', 1),\n",
       " ('approvement local medical', 1),\n",
       " ('local medical authorities', 1),\n",
       " ('ablatherm devices available', 1),\n",
       " ('available anymore trial', 1),\n",
       " ('withdrawal support drug', 1),\n",
       " ('pharmaceutical support novartis', 1),\n",
       " ('pharmaceutical company support', 1),\n",
       " ('financial support funder', 1),\n",
       " ('withdrawal drug supply.', 1),\n",
       " ('current health situation,', 1),\n",
       " ('significant resumption recruitment', 1),\n",
       " ('recent advances immunotherapy', 1),\n",
       " ('scientific question significant', 1),\n",
       " ('re-open another time', 1),\n",
       " ('able enroll enough', 1),\n",
       " ('enough participants due', 1),\n",
       " ('due shortage study', 1),\n",
       " ('demonstrate significant activity.', 1),\n",
       " ('significant activity. meet', 1),\n",
       " ('activity. meet primary', 1),\n",
       " ('weight loss center', 1),\n",
       " ('wish wait data', 1),\n",
       " ('available using substance.', 1),\n",
       " ('initiate recruitment protocol', 1),\n",
       " ('unable procure supplement', 1),\n",
       " ('unable enroll eligible', 1),\n",
       " ('eligible subjects study.', 1),\n",
       " ('successful raising money', 1),\n",
       " ('able work logistics', 1),\n",
       " ('able secure irb', 1),\n",
       " ('able recruit participants.', 1),\n",
       " ('enough participants funding', 1),\n",
       " ('experienced recruitment difficulties', 1),\n",
       " ('sub-study nct02371889, 13', 1),\n",
       " ('nct02371889, 13 week,', 1),\n",
       " ('double-blind, trial topiramate', 1),\n",
       " ('due problems recruiting', 1),\n",
       " ('alcoholic subjects hiv.', 1),\n",
       " ('low thus decided', 1),\n",
       " ('new populations requires', 1),\n",
       " ('impossible measure adrenomedullin', 1),\n",
       " ('interesting clinical laboratorial', 1),\n",
       " ('clinical laboratorial results.', 1),\n",
       " ('final results due', 1),\n",
       " ('due interim analysis.', 1),\n",
       " ('standard care bmi', 1),\n",
       " ('sensitive evaluate effect', 1),\n",
       " ('postoperative ifna treatment', 1),\n",
       " ('decided test newly', 1),\n",
       " ('several years added', 1),\n",
       " ('appropriate sample size.', 1),\n",
       " ('failed recruit patients', 1),\n",
       " ('potential candidates reaching', 1),\n",
       " ('students/research staff able', 1),\n",
       " ('able continue data', 1),\n",
       " ('enough research funding.', 1),\n",
       " ('funding support study.', 1),\n",
       " ('want start case', 1),\n",
       " ('close study. unable', 1),\n",
       " ('unable perform study', 1),\n",
       " ('due current pandemic.', 1),\n",
       " ('close study come', 1),\n",
       " ('new study design.', 1),\n",
       " ('decided change protocol', 1),\n",
       " ('national medical insurance', 1),\n",
       " ('medical insurance owing', 1),\n",
       " ('candidate eligible recruitment', 1),\n",
       " ('total 19 patients', 1),\n",
       " ('interim analysis. less', 1),\n",
       " ('initial 19 patients.', 1),\n",
       " ('chose maximize iterative', 1),\n",
       " ('iterative treatment development', 1),\n",
       " ('initial open trial', 1),\n",
       " ('open trial (increased', 1),\n",
       " ('test drug (vadenafil)', 1),\n",
       " ('carry trail taiwan.', 1),\n",
       " ('trail never started.', 1),\n",
       " ('arrived end inclusion', 1),\n",
       " ('patient recruited. submit', 1),\n",
       " ('slow recruitment (=2/3', 1),\n",
       " ('possible enroll sufficient', 1),\n",
       " ('worthwhile conclusions study.', 1),\n",
       " ('annual irb progress', 1),\n",
       " ('irb progress report', 1),\n",
       " ('meet primary endpoint,', 1),\n",
       " ('primary endpoint, follow', 1),\n",
       " ('voluntary halt due', 1),\n",
       " ('due fda clinical', 1),\n",
       " ('preliminary non-clinical findings.', 1),\n",
       " ('sponsor investigate anticipated', 1),\n",
       " ('small percentage enrolled', 1),\n",
       " ('non-invasive support small', 1),\n",
       " ('small chance us', 1),\n",
       " ('slow recruitment, sufficient', 1),\n",
       " ('slow recruitment (only', 1),\n",
       " ('slow enrollment.study entry', 1),\n",
       " ('w/local standards care', 1),\n",
       " ('slow enrollment target', 1),\n",
       " ('slow enrollment participants', 1),\n",
       " ('slow accrual; terminated', 1),\n",
       " ('allow resources utilized', 1),\n",
       " ('utilized effectively studies.', 1),\n",
       " ('studies. data analysis', 1),\n",
       " ('poor patient recruitement', 1),\n",
       " ('low recruitment. covid-19', 1),\n",
       " ('covid-19 pandemic patients', 1),\n",
       " ('pandemic patients high', 1),\n",
       " ('low patient recruitment,', 1),\n",
       " ('due low access', 1),\n",
       " ('low access study', 1),\n",
       " ('eligibility criteria, none', 1),\n",
       " ('difficult recruit patients/slow', 1),\n",
       " ('patients/slow recruitment(2 patients', 1),\n",
       " ('ventricular rate af', 1),\n",
       " ('much lower expected', 1),\n",
       " ('vapocoolant effective controlling', 1),\n",
       " ('effective controlling pain', 1),\n",
       " ('due covid-19 restrictions-will', 1),\n",
       " ('covid-19 restrictions-will resume', 1),\n",
       " ('restrictions-will resume able', 1),\n",
       " ('safe immunogenic 8', 1),\n",
       " ('immunogenic 8 participants;', 1),\n",
       " ('utsw family medicine', 1),\n",
       " ('university. attempts implement', 1),\n",
       " ('ut-irb insists protocol', 1),\n",
       " ('ut/mhhs may resume', 1),\n",
       " ('usc icoi university', 1),\n",
       " ('patent interventional dietary', 1),\n",
       " ('interventional dietary supplement.', 1),\n",
       " ('usaf regulatory concerns', 1),\n",
       " (\"urogen's rtgeltm delivery\", 1),\n",
       " ('allergan plc activation', 1),\n",
       " ('plc activation trial.', 1),\n",
       " ('urgent shift among', 1),\n",
       " ('clinical sites toward', 1),\n",
       " ('covid-19 pandemic;impacted feasibility', 1),\n",
       " ('pandemic;impacted feasibility completing', 1),\n",
       " ('shelf-life current ip', 1),\n",
       " ('current ip supply', 1),\n",
       " ('uptake drug tumour', 1),\n",
       " ('update clinical development:', 1),\n",
       " ('clinical development: discussions', 1),\n",
       " ('update technical documentation', 1),\n",
       " ('technical documentation device', 1),\n",
       " ('unusual high frequency', 1),\n",
       " ('high frequency elevated', 1),\n",
       " ('liver function tests.', 1),\n",
       " ('unsufficient referrals recruitment', 1),\n",
       " ('unsufficient patient recruitment', 1),\n",
       " ('unsuccessful recruiting patients,', 1),\n",
       " ('unsuccessful attempts recruit', 1),\n",
       " ('unspecified business decision/strategic', 1),\n",
       " ('unsatisfactory patient accrual', 1),\n",
       " ('unsatisfactory filter deployment', 1),\n",
       " ('unsatisfactory efficacy data', 1),\n",
       " ('unresolvable inability recruit', 1),\n",
       " ('unrelated serious adverse', 1),\n",
       " ('adverse events involving', 1),\n",
       " ('unrealizable wishes national', 1),\n",
       " ('unreached recruitment objectives', 1),\n",
       " ('unplanned interim analysis', 1),\n",
       " ('interim analysis dsmb', 1),\n",
       " ('possible reduced response', 1),\n",
       " ('reduced response rate', 1),\n",
       " ('population. analysis pending.', 1),\n",
       " ('unobtainable sample size', 1),\n",
       " ('unlikely show statistical', 1),\n",
       " ('statistical significance slow', 1),\n",
       " ('unlikely provide evidence', 1),\n",
       " ('unfortunately, trial take', 1),\n",
       " ('unfortunately, co-pi lead', 1),\n",
       " ('co-pi lead community', 1),\n",
       " ('unfortunately, phase iii', 1),\n",
       " ('clinical study (gem+s-1', 1),\n",
       " ('(gem+s-1 vs gem', 1),\n",
       " ('unforeseen difficulty recruiting', 1),\n",
       " ('unforeseen feasibility issues', 1),\n",
       " ('meant study seem', 1),\n",
       " ('viable current form.', 1),\n",
       " ('unforeseen cost restrictions', 1),\n",
       " ('unforeseen complications due', 1),\n",
       " ('due covid-19 funding', 1),\n",
       " ('unfeasible low accrual', 1),\n",
       " ('unfavourable ethical opinion,', 1),\n",
       " ('ethical opinion, principally', 1),\n",
       " ('inadequate sample size', 1),\n",
       " ('unexpected toxicities, likely', 1),\n",
       " ('likely due til/il-12', 1),\n",
       " ('due til/il-12 &', 1),\n",
       " ('low % durable', 1),\n",
       " ('unexpected non-serious adverse', 1),\n",
       " ('non-serious adverse events', 1),\n",
       " ('unexpected low willingness', 1),\n",
       " ('low willingness patient', 1),\n",
       " ('unexpected histological findings', 1),\n",
       " ('unexpected high grade', 1),\n",
       " ('high grade mucositis', 1),\n",
       " ('unexpected difficulties recruiting', 1),\n",
       " ('unexpected alcohol use', 1),\n",
       " ('preliminary analysis half', 1),\n",
       " ('unexpected adverse events', 1),\n",
       " ('unavailable study resources', 1),\n",
       " ('unavailability investigational device', 1),\n",
       " ('unanticipated side effects', 1),\n",
       " ('unacceptable safety profile', 1),\n",
       " ('unacceptable incidence wound', 1),\n",
       " ('unacceptable high drop-out', 1),\n",
       " ('unacceptable frequency hypoglycemia', 1),\n",
       " ('unable validate analytical', 1),\n",
       " ('unable sufficiently recruit', 1),\n",
       " ('unable successfully recruit', 1),\n",
       " ('recruit subjects study.', 1),\n",
       " ('unable staff project', 1),\n",
       " ('unable secure supply', 1),\n",
       " ('unable secure funding.', 1),\n",
       " ('unable secure clinic', 1),\n",
       " ('clinic support conducting', 1),\n",
       " ('unable renegotiate expired', 1),\n",
       " ('unable recruit/maintain participants', 1),\n",
       " ('unable recruit/accrue adequate', 1),\n",
       " ('adequate numbers participants', 1),\n",
       " ('due limited number', 1),\n",
       " ('unable recruit projected', 1),\n",
       " ('patient number. analyses', 1),\n",
       " ('unable recruit targeted', 1),\n",
       " ('unable recruit target', 1),\n",
       " ('suitable subjects within', 1),\n",
       " ('reasonable time period.', 1),\n",
       " ('sufficient number patients.', 1),\n",
       " ('unable recruit subjects.', 1),\n",
       " ('unable recruit subjects,', 1),\n",
       " ('active treatment instead', 1),\n",
       " ('short length stay', 1),\n",
       " ('unable recruit qualified', 1),\n",
       " ('timely fashion unable', 1),\n",
       " ('due competing studies', 1),\n",
       " ('unable recruit necessary', 1),\n",
       " ('unable recruit 2', 1),\n",
       " ('enough subjects attain', 1),\n",
       " ('minimum sample size.', 1),\n",
       " ('enough patients continue', 1),\n",
       " ('enough eligible subjects', 1),\n",
       " ('unable recruit eligible', 1),\n",
       " ('unable recruit covid-19', 1),\n",
       " ('covid-19 epidemic restrictions', 1),\n",
       " ('epidemic restrictions associated', 1),\n",
       " ('due school closures', 1),\n",
       " ('due covid limitiations', 1),\n",
       " ('narrow enrollment requirements', 1),\n",
       " ('adequate trial participants', 1),\n",
       " ('adequate numbers study', 1),\n",
       " ('required time frame.', 1),\n",
       " ('unable recruit -', 1),\n",
       " ('multiple reasons.- inclusion/exclusion', 1),\n",
       " ('reasons.- inclusion/exclusion criteria', 1),\n",
       " ('strict th emain', 1),\n",
       " ('unable reach target', 1),\n",
       " ('unable reach sample', 1),\n",
       " ('unable reach recruitment', 1)]"
      ]
     },
     "execution_count": 41,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "n_grams_dist_jj_3=FreqDist(word_pos_3)\n",
    "n_grams_dist_jj_3.most_common(1000)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "difficulty in accrual of study subjects, small numbers of potential subjects\n"
     ]
    }
   ],
   "source": [
    "for sent in lis:\n",
    "    if sent.find('potential')!=-1 and sent.find('difficult')!=-1:\n",
    "        print(sent)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [],
   "source": [
    "r=RegexpTokenizer(r'[A-Za-z]+')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {},
   "outputs": [],
   "source": [
    "n_grams=[]\n",
    "words=[]\n",
    "for sent in lis:\n",
    "    for word in r.tokenize(sent.lower()):\n",
    "        if word not in stop_words:\n",
    "            words.append(word)\n",
    "for tup in ngrams(words,3):\n",
    "        n_grams.append(tup)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[(('slow', 'accrual', 'slow'), 277),\n",
       " (('accrual', 'slow', 'accrual'), 277),\n",
       " (('study', 'terminated', 'due'), 194),\n",
       " (('lack', 'funding', 'lack'), 171),\n",
       " (('funding', 'lack', 'funding'), 169),\n",
       " (('low', 'accrual', 'low'), 168),\n",
       " (('accrual', 'low', 'accrual'), 167),\n",
       " (('decision', 'sponsor', 'decision'), 136),\n",
       " (('sponsor', 'decision', 'sponsor'), 135),\n",
       " (('detailed', 'description', 'see'), 120),\n",
       " (('lack', 'enrollment', 'lack'), 113),\n",
       " (('enrollment', 'lack', 'enrollment'), 111),\n",
       " (('pi', 'left', 'institution'), 109),\n",
       " (('see', 'termination', 'reason'), 104),\n",
       " (('description', 'see', 'termination'), 103),\n",
       " (('termination', 'reason', 'detailed'), 103),\n",
       " (('reason', 'detailed', 'description'), 103),\n",
       " (('slow', 'enrollment', 'slow'), 100),\n",
       " (('enrollment', 'slow', 'enrollment'), 100),\n",
       " (('study', 'terminated', 'early'), 96),\n",
       " (('enrollment', 'low', 'enrollment'), 90),\n",
       " (('funding', 'funding', 'funding'), 90),\n",
       " (('participants', 'enrolled', 'participants'), 89),\n",
       " (('low', 'enrollment', 'low'), 88),\n",
       " (('study', 'stopped', 'due'), 87),\n",
       " (('enrolled', 'participants', 'enrolled'), 87),\n",
       " (('poor', 'accrual', 'poor'), 85),\n",
       " (('accrual', 'poor', 'accrual'), 85),\n",
       " (('covid', 'covid', 'covid'), 85),\n",
       " (('recruitment', 'slow', 'recruitment'), 78),\n",
       " (('slow', 'recruitment', 'slow'), 77),\n",
       " (('due', 'slow', 'accrual'), 76),\n",
       " (('due', 'covid', 'pandemic'), 73),\n",
       " (('terminated', 'early', 'due'), 72),\n",
       " (('left', 'institution', 'pi'), 70),\n",
       " (('poor', 'recruitment', 'poor'), 68),\n",
       " (('poor', 'enrollment', 'poor'), 68),\n",
       " (('institution', 'pi', 'left'), 68),\n",
       " (('enrollment', 'poor', 'enrollment'), 67),\n",
       " (('investigator', 'left', 'institution'), 65),\n",
       " (('recruitment', 'poor', 'recruitment'), 65),\n",
       " (('lack', 'recruitment', 'lack'), 64),\n",
       " (('recruitment', 'lack', 'recruitment'), 63),\n",
       " (('lack', 'accrual', 'lack'), 61),\n",
       " (('due', 'low', 'enrollment'), 60),\n",
       " (('accrual', 'lack', 'accrual'), 60),\n",
       " (('lack', 'efficacy', 'lack'), 59),\n",
       " (('business', 'decision', 'business'), 59),\n",
       " (('decision', 'business', 'decision'), 58),\n",
       " (('efficacy', 'lack', 'efficacy'), 57),\n",
       " (('due', 'poor', 'accrual'), 54),\n",
       " (('suspended', 'due', 'covid'), 53),\n",
       " (('low', 'recruitment', 'low'), 53),\n",
       " (('recruitment', 'low', 'recruitment'), 52),\n",
       " (('terminated', 'due', 'lack'), 51),\n",
       " (('terminated', 'due', 'low'), 49),\n",
       " (('study', 'never', 'started'), 49),\n",
       " (('due', 'lack', 'efficacy'), 48),\n",
       " (('insufficient', 'enrollment', 'insufficient'), 48),\n",
       " (('due', 'slow', 'enrollment'), 47),\n",
       " (('enrollment', 'insufficient', 'enrollment'), 47),\n",
       " (('terminated', 'due', 'slow'), 46),\n",
       " (('principal', 'investigator', 'left'), 46),\n",
       " (('enrollment', 'study', 'terminated'), 45),\n",
       " (('due', 'lack', 'funding'), 44),\n",
       " (('see', 'detailed', 'description'), 43),\n",
       " (('recruitment', 'difficulties', 'recruitment'), 43),\n",
       " (('difficulties', 'recruitment', 'difficulties'), 43),\n",
       " (('insufficient', 'recruitment', 'insufficient'), 43),\n",
       " (('due', 'low', 'accrual'), 42),\n",
       " (('recruitment', 'insufficient', 'recruitment'), 42),\n",
       " (('administratively', 'complete', 'administratively'), 42),\n",
       " (('due', 'slow', 'recruitment'), 41),\n",
       " (('complete', 'administratively', 'complete'), 41),\n",
       " (('study', 'closed', 'due'), 36),\n",
       " (('business', 'reasons', 'business'), 36),\n",
       " (('low', 'recruitment', 'rate'), 35),\n",
       " (('study', 'withdrawn', 'due'), 34),\n",
       " (('accrual', 'study', 'terminated'), 34),\n",
       " (('reasons', 'business', 'reasons'), 34),\n",
       " (('covid', 'pandemic', 'covid'), 34),\n",
       " (('due', 'safety', 'concerns'), 33),\n",
       " (('study', 'halted', 'prematurely'), 31),\n",
       " (('temporarily', 'suspended', 'due'), 31),\n",
       " (('low', 'enrollment', 'study'), 30),\n",
       " (('accrual', 'terminated', 'due'), 30),\n",
       " (('pandemic', 'covid', 'pandemic'), 30),\n",
       " (('enrollment', 'enrollment', 'enrollment'), 29),\n",
       " (('reasons', 'study', 'terminated'), 28),\n",
       " (('loss', 'funding', 'loss'), 28),\n",
       " (('recruitment', 'rate', 'low'), 27),\n",
       " (('funding', 'loss', 'funding'), 27),\n",
       " (('company', 'decision', 'company'), 27),\n",
       " (('low', 'accrual', 'rate'), 26),\n",
       " (('never', 'started', 'study'), 26),\n",
       " (('difficulty', 'recruiting', 'patients'), 26),\n",
       " (('decision', 'company', 'decision'), 26),\n",
       " (('planned', 'interim', 'analysis'), 25),\n",
       " (('slow', 'accrual', 'study'), 25),\n",
       " (('interim', 'analysis', 'showed'), 25),\n",
       " (('futility', 'futility', 'futility'), 25),\n",
       " (('rate', 'low', 'recruitment'), 24),\n",
       " (('covid', 'pandemic', 'study'), 24),\n",
       " (('paused', 'due', 'covid'), 24),\n",
       " (('due', 'low', 'recruitment'), 23),\n",
       " (('safety', 'efficacy', 'concerns'), 23),\n",
       " (('terminated', 'due', 'poor'), 23),\n",
       " (('safety', 'concerns', 'study'), 23),\n",
       " (('study', 'terminated', 'prematurely'), 23),\n",
       " (('lack', 'efficacy', 'study'), 23),\n",
       " (('stopped', 'due', 'lack'), 23),\n",
       " (('patients', 'enrolled', 'patients'), 23),\n",
       " (('data', 'monitoring', 'committee'), 22),\n",
       " (('left', 'institution', 'study'), 22),\n",
       " (('started', 'study', 'never'), 22),\n",
       " (('accrual', 'study', 'closed'), 22),\n",
       " (('study', 'never', 'initiated'), 22),\n",
       " (('lack', 'funds', 'lack'), 22),\n",
       " (('insufficient', 'funding', 'insufficient'), 22),\n",
       " (('insufficient', 'accrual', 'insufficient'), 22),\n",
       " (('funding', 'withdrawn', 'funding'), 22),\n",
       " (('decided', 'close', 'study'), 21),\n",
       " (('patients', 'unable', 'recruit'), 21),\n",
       " (('decided', 'terminate', 'study'), 21),\n",
       " (('decision', 'terminate', 'study'), 21),\n",
       " (('left', 'institution', 'investigator'), 21),\n",
       " (('institution', 'investigator', 'left'), 21),\n",
       " (('difficulty', 'recruitment', 'difficulty'), 21),\n",
       " (('funds', 'lack', 'funds'), 21),\n",
       " (('funding', 'insufficient', 'funding'), 21),\n",
       " (('accrual', 'insufficient', 'accrual'), 21),\n",
       " (('patients', 'difficulty', 'recruiting'), 21),\n",
       " (('due', 'lack', 'accrual'), 20),\n",
       " (('slow', 'enrollment', 'study'), 20),\n",
       " (('early', 'due', 'slow'), 20),\n",
       " (('recruitment', 'study', 'terminated'), 20),\n",
       " (('study', 'terminated', 'sponsor'), 20),\n",
       " (('institution', 'principal', 'investigator'), 20),\n",
       " (('development', 'program', 'terminated'), 20),\n",
       " (('recruitment', 'difficulty', 'recruitment'), 20),\n",
       " (('withdrawn', 'funding', 'withdrawn'), 20),\n",
       " (('funding', 'unavailable', 'funding'), 20),\n",
       " (('study', 'terminated', 'based'), 19),\n",
       " (('pi', 'leaving', 'institution'), 19),\n",
       " (('participants', 'longer', 'examined'), 19),\n",
       " (('enrolled', 'patients', 'enrolled'), 19),\n",
       " (('unavailable', 'funding', 'unavailable'), 19),\n",
       " (('administrative', 'reasons', 'administrative'), 19),\n",
       " (('study', 'never', 'opened'), 18),\n",
       " (('study', 'suspended', 'due'), 18),\n",
       " (('efficacy', 'study', 'terminated'), 18),\n",
       " (('temporarily', 'paused', 'due'), 18),\n",
       " (('enrolling', 'participants', 'halted'), 18),\n",
       " (('slow', 'accrual', 'due'), 18),\n",
       " (('enrollment', 'terminated', 'due'), 18),\n",
       " (('due', 'covid', 'expected'), 18),\n",
       " (('detailed', 'description', 'termination'), 18),\n",
       " (('description', 'termination', 'reason'), 18),\n",
       " (('difficulty', 'recruiting', 'difficulty'), 18),\n",
       " (('recruiting', 'patients', 'difficulty'), 18),\n",
       " (('reasons', 'administrative', 'reasons'), 18),\n",
       " (('due', 'lack', 'enrollment'), 17),\n",
       " (('slow', 'recruitment', 'rate'), 17),\n",
       " (('poor', 'accrual', 'study'), 17),\n",
       " (('business', 'reasons', 'study'), 17),\n",
       " (('concerns', 'study', 'terminated'), 17),\n",
       " (('due', 'poor', 'enrollment'), 17),\n",
       " (('lack', 'funding', 'study'), 17),\n",
       " (('enrollment', 'study', 'stopped'), 17),\n",
       " (('accrual', 'rate', 'low'), 17),\n",
       " (('recruiting', 'enrolling', 'participants'), 17),\n",
       " (('terminated', 'terminated', 'terminated'), 17),\n",
       " (('suspension', 'irb', 'approval'), 17),\n",
       " (('inadequate', 'enrollment', 'inadequate'), 17),\n",
       " (('enrollment', 'inadequate', 'enrollment'), 17),\n",
       " (('low', 'accrual', 'study'), 16),\n",
       " (('sponsor', 'study', 'terminated'), 16),\n",
       " (('never', 'initiated', 'study'), 16),\n",
       " (('stopped', 'due', 'low'), 16),\n",
       " (('covid', 'expected', 'resume'), 16),\n",
       " (('description', 'see', 'detailed'), 16),\n",
       " (('recruitment', 'inadequate', 'recruitment'), 16),\n",
       " (('rate', 'low', 'accrual'), 16),\n",
       " (('decision', 'investigator', 'decision'), 16),\n",
       " (('inadequate', 'recruitment', 'inadequate'), 16),\n",
       " (('accrual', 'due', 'poor'), 16),\n",
       " (('due', 'covid', 'due'), 16),\n",
       " (('recruiting', 'difficulty', 'recruiting'), 16),\n",
       " (('due', 'poor', 'recruitment'), 15),\n",
       " (('slow', 'accrual', 'terminated'), 15),\n",
       " (('unable', 'recruit', 'patients'), 15),\n",
       " (('early', 'due', 'lack'), 15),\n",
       " (('slow', 'recruitment', 'study'), 15),\n",
       " (('decision', 'study', 'terminated'), 15),\n",
       " (('study', 'study', 'terminated'), 15),\n",
       " (('study', 'funded', 'study'), 15),\n",
       " (('closed', 'due', 'slow'), 15),\n",
       " (('left', 'institution', 'principal'), 15),\n",
       " (('ended', 'funding', 'ended'), 15),\n",
       " (('early', 'termination', 'due'), 15),\n",
       " (('participants', 'halted', 'prematurely'), 15),\n",
       " (('halted', 'prematurely', 'resume'), 15),\n",
       " (('resume', 'participants', 'longer'), 15),\n",
       " (('problems', 'recruitment', 'problems'), 15),\n",
       " (('pi', 'longer', 'institution'), 15),\n",
       " (('accrual', 'accrual', 'accrual'), 15),\n",
       " (('investigator', 'decision', 'investigator'), 15),\n",
       " (('funding', 'ended', 'funding'), 15),\n",
       " (('failure', 'recruit', 'failure'), 15),\n",
       " (('poor', 'accrual', 'due'), 15),\n",
       " (('covid', 'due', 'covid'), 15),\n",
       " (('accrual', 'closed', 'due'), 15),\n",
       " (('prior', 'enrollment', 'first'), 14),\n",
       " (('withdrawn', 'due', 'lack'), 14),\n",
       " (('meet', 'primary', 'endpoint'), 14),\n",
       " (('inclusion', 'exclusion', 'criteria'), 14),\n",
       " (('stopped', 'early', 'due'), 14),\n",
       " (('prematurely', 'terminated', 'due'), 14),\n",
       " (('due', 'business', 'reasons'), 14),\n",
       " (('sponsor', 'withdrew', 'support'), 14),\n",
       " (('study', 'prematurely', 'terminated'), 14),\n",
       " (('closed', 'early', 'due'), 14),\n",
       " (('data', 'safety', 'monitoring'), 14),\n",
       " (('due', 'sponsor', 'decision'), 14),\n",
       " (('study', 'stopped', 'early'), 14),\n",
       " (('initiated', 'study', 'never'), 14),\n",
       " (('recruitment', 'rate', 'slow'), 14),\n",
       " (('program', 'terminated', 'development'), 14),\n",
       " (('low', 'enrollment', 'rate'), 14),\n",
       " (('terminated', 'sponsor', 'terminated'), 14),\n",
       " (('sponsor', 'terminated', 'sponsor'), 14),\n",
       " (('sponsor', 'decision', 'due'), 14),\n",
       " (('accrual', 'due', 'slow'), 14),\n",
       " (('recruitment', 'recruitment', 'recruitment'), 14),\n",
       " (('recruitment', 'problems', 'recruitment'), 14),\n",
       " (('funding', 'available', 'funding'), 14),\n",
       " (('recruit', 'failure', 'recruit'), 14),\n",
       " (('difficulty', 'enrollment', 'difficulty'), 14),\n",
       " (('covid', 'pandemic', 'due'), 14),\n",
       " (('business', 'objectives', 'changed'), 14),\n",
       " (('participants', 'unable', 'recruit'), 13),\n",
       " (('terminated', 'prematurely', 'due'), 13),\n",
       " (('due', 'administrative', 'reasons'), 13),\n",
       " (('patients', 'enrolled', 'study'), 13),\n",
       " (('study', 'closed', 'early'), 13),\n",
       " (('due', 'covid', 'study'), 13),\n",
       " (('terminated', 'development', 'program'), 13),\n",
       " (('lack', 'eligible', 'patients'), 13),\n",
       " (('research', 'cancelled', 'research'), 13),\n",
       " (('recruitment', 'challenges', 'recruitment'), 13),\n",
       " (('challenges', 'recruitment', 'challenges'), 13),\n",
       " (('funded', 'funded', 'funded'), 13),\n",
       " (('funding', 'issues', 'funding'), 13),\n",
       " (('irb', 'approval', 'enrollment'), 13),\n",
       " (('future', 'suspension', 'irb'), 13),\n",
       " (('enrollment', 'difficulty', 'enrollment'), 13),\n",
       " (('objectives', 'changed', 'business'), 13),\n",
       " (('terminated', 'study', 'due'), 12),\n",
       " (('subjects', 'unable', 'recruit'), 12),\n",
       " (('trial', 'terminated', 'early'), 12),\n",
       " (('closed', 'due', 'poor'), 12),\n",
       " (('recruitment', 'study', 'stopped'), 12),\n",
       " (('study', 'discontinued', 'due'), 12),\n",
       " (('interim', 'analysis', 'study'), 12),\n",
       " (('closed', 'due', 'lack'), 12),\n",
       " (('results', 'interim', 'analysis'), 12),\n",
       " (('prematurely', 'resume', 'participants'), 12),\n",
       " (('longer', 'examined', 'treated'), 12),\n",
       " (('sponsor', 'decision', 'terminate'), 12),\n",
       " (('never', 'started', 'never'), 12),\n",
       " (('lack', 'financial', 'support'), 12),\n",
       " (('clinical', 'hold', 'fda'), 12),\n",
       " (('cancelled', 'research', 'cancelled'), 12),\n",
       " (('recruitment', 'issues', 'recruitment'), 12),\n",
       " (('please', 'see', 'detailed'), 12),\n",
       " (('management', 'decision', 'management'), 12),\n",
       " (('decision', 'management', 'decision'), 12),\n",
       " (('lack', 'patients', 'lack'), 12),\n",
       " (('issues', 'funding', 'issues'), 12),\n",
       " (('due', 'covid', 'enrollment'), 12),\n",
       " (('changed', 'business', 'objectives'), 12),\n",
       " (('enrollment', 'first', 'participant'), 11),\n",
       " (('inability', 'recruit', 'patients'), 11),\n",
       " (('risk', 'benefit', 'ratio'), 11),\n",
       " (('unable', 'recruit', 'subjects'), 11),\n",
       " (('terminate', 'study', 'early'), 11),\n",
       " (('due', 'lack', 'recruitment'), 11),\n",
       " (('administrative', 'reasons', 'study'), 11),\n",
       " (('early', 'due', 'poor'), 11),\n",
       " (('participants', 'enrolled', 'study'), 11),\n",
       " (('business', 'decision', 'safety'), 11),\n",
       " (('terminated', 'due', 'insufficient'), 11),\n",
       " (('difficulty', 'recruiting', 'subjects'), 11),\n",
       " (('halted', 'prematurely', 'due'), 11),\n",
       " (('sponsor', 'terminated', 'study'), 11),\n",
       " (('safety', 'monitoring', 'board'), 11),\n",
       " (('benefit', 'risk', 'profile'), 11),\n",
       " (('sponsor', 'decision', 'based'), 11),\n",
       " (('rate', 'slow', 'recruitment'), 11),\n",
       " (('safety', 'safety', 'safety'), 11),\n",
       " (('issues', 'recruitment', 'issues'), 11),\n",
       " (('termination', 'reason', 'please'), 11),\n",
       " (('reason', 'please', 'see'), 11),\n",
       " (('longer', 'institution', 'pi'), 11),\n",
       " (('funding', 'obtained', 'funding'), 11),\n",
       " (('difficulties', 'recruiting', 'patients'), 11),\n",
       " (('patients', 'lack', 'patients'), 11),\n",
       " (('expected', 'resume', 'future'), 11),\n",
       " (('resume', 'future', 'suspension'), 11),\n",
       " (('pandemic', 'due', 'covid'), 11),\n",
       " (('company', 'dissolved', 'company'), 11),\n",
       " (('concerns', 'business', 'decision'), 11),\n",
       " (('halted', 'prematurely', 'prior'), 10),\n",
       " (('prematurely', 'prior', 'enrollment'), 10),\n",
       " (('due', 'lack', 'eligible'), 10),\n",
       " (('recruit', 'sufficient', 'number'), 10),\n",
       " (('unable', 'recruit', 'enough'), 10),\n",
       " (('unable', 'enroll', 'patients'), 10),\n",
       " (('trial', 'terminated', 'due'), 10),\n",
       " (('early', 'due', 'low'), 10),\n",
       " (('trial', 'initiated', 'trial'), 10),\n",
       " (('based', 'interim', 'analysis'), 10),\n",
       " (('safety', 'efficacy', 'study'), 10),\n",
       " (('terminated', 'due', 'covid'), 10),\n",
       " (('study', 'temporarily', 'suspended'), 10),\n",
       " (('sponsor', 'decision', 'study'), 10),\n",
       " (('funded', 'study', 'funded'), 10),\n",
       " (('closed', 'due', 'low'), 10),\n",
       " (('sponsor', 'decided', 'discontinue'), 10),\n",
       " (('study', 'due', 'low'), 10),\n",
       " (('lack', 'accrual', 'study'), 10),\n",
       " (('strategic', 'considerations', 'strategic'), 10),\n",
       " (('sponsor', 'withdrew', 'funding'), 10),\n",
       " (('change', 'study', 'design'), 10),\n",
       " (('safety', 'concerns', 'safety'), 10),\n",
       " (('patients', 'difficulties', 'recruiting'), 10),\n",
       " (('institution', 'pi', 'longer'), 10),\n",
       " (('leaving', 'institution', 'pi'), 10),\n",
       " (('enough', 'patients', 'enough'), 10),\n",
       " (('available', 'funding', 'available'), 10),\n",
       " (('financial', 'support', 'lack'), 10),\n",
       " (('patients', 'inability', 'recruit'), 10),\n",
       " (('subjects', 'difficulty', 'recruiting'), 10),\n",
       " (('administrative', 'administrative', 'administrative'), 10),\n",
       " (('unable', 'recruit', 'sufficient'), 9),\n",
       " (('unable', 'recruit', 'participants'), 9),\n",
       " (('decided', 'stop', 'study'), 9),\n",
       " (('sufficient', 'number', 'patients'), 9),\n",
       " (('recruit', 'patients', 'unable'), 9),\n",
       " (('unable', 'recruit', 'unable'), 9),\n",
       " (('subjects', 'enrolled', 'study'), 9),\n",
       " (('initiated', 'trial', 'initiated'), 9),\n",
       " (('toxicity', 'toxicity', 'toxicity'), 9),\n",
       " (('trial', 'prematurely', 'terminated'), 9),\n",
       " (('study', 'withdrawn', 'prior'), 9),\n",
       " (('due', 'business', 'decision'), 9),\n",
       " (('business', 'decision', 'sponsor'), 9),\n",
       " (('poor', 'enrollment', 'study'), 9),\n",
       " (('funding', 'study', 'terminated'), 9),\n",
       " (('withdrew', 'support', 'study'), 9),\n",
       " (('accrual', 'study', 'stopped'), 9),\n",
       " (('stopped', 'due', 'slow'), 9),\n",
       " (('insufficient', 'patient', 'recruitment'), 9),\n",
       " (('reasons', 'related', 'safety'), 9),\n",
       " (('analysis', 'study', 'terminated'), 9),\n",
       " (('due', 'insufficient', 'efficacy'), 9),\n",
       " (('based', 'business', 'decision'), 9),\n",
       " (('data', 'study', 'terminated'), 9),\n",
       " (('study', 'initiated', 'study'), 9),\n",
       " (('terminate', 'study', 'due'), 9),\n",
       " (('primary', 'efficacy', 'endpoint'), 9),\n",
       " (('study', 'termination', 'due'), 9),\n",
       " (('poor', 'accrual', 'terminated'), 9),\n",
       " (('slow', 'enrollment', 'terminated'), 9),\n",
       " (('enrollment', 'due', 'slow'), 9),\n",
       " (('poor', 'patient', 'recruitment'), 9),\n",
       " (('started', 'never', 'started'), 9),\n",
       " (('considerations', 'strategic', 'considerations'), 9),\n",
       " (('study', 'sponsor', 'decision'), 9),\n",
       " (('decision', 'based', 'portfolio'), 9),\n",
       " (('based', 'portfolio', 'prioritization'), 9),\n",
       " (('portfolio', 'prioritization', 'sponsor'), 9),\n",
       " (('prioritization', 'sponsor', 'decision'), 9),\n",
       " (('decision', 'safety', 'efficacy'), 9),\n",
       " (('decided', 'discontinue', 'study'), 9),\n",
       " (('slow', 'enrollment', 'due'), 9),\n",
       " (('concerns', 'safety', 'concerns'), 9),\n",
       " (('repros', 'stopped', 'study'), 9),\n",
       " (('put', 'study', 'hold'), 9),\n",
       " (('recruiting', 'patients', 'difficulties'), 9),\n",
       " (('institution', 'pi', 'leaving'), 9),\n",
       " (('pi', 'decision', 'pi'), 9),\n",
       " (('patients', 'enough', 'patients'), 9),\n",
       " (('funding', 'received', 'funding'), 9),\n",
       " (('low', 'inclusion', 'rate'), 9),\n",
       " (('inclusion', 'rate', 'low'), 9),\n",
       " (('enrollment', 'rate', 'low'), 9),\n",
       " (('rate', 'low', 'enrollment'), 9),\n",
       " (('lack', 'resources', 'lack'), 9),\n",
       " (('support', 'lack', 'financial'), 9),\n",
       " (('covid', 'enrollment', 'study'), 9),\n",
       " (('enrollment', 'study', 'activities'), 9),\n",
       " (('study', 'activities', 'temporarily'), 9),\n",
       " (('activities', 'temporarily', 'suspended'), 9),\n",
       " (('dissolved', 'company', 'dissolved'), 9),\n",
       " (('company', 'decision', 'taken'), 9),\n",
       " (('decision', 'taken', 'light'), 9),\n",
       " (('taken', 'light', 'demands'), 9),\n",
       " (('light', 'demands', 'certain'), 9),\n",
       " (('demands', 'certain', 'national'), 9),\n",
       " (('certain', 'national', 'health'), 9),\n",
       " (('national', 'health', 'authorities'), 9),\n",
       " (('health', 'authorities', 'company'), 9),\n",
       " (('authorities', 'company', 'decision'), 9),\n",
       " (('efficacy', 'concerns', 'business'), 9),\n",
       " (('study', 'withdrawn', 'study'), 8),\n",
       " (('accrual', 'withdrawn', 'due'), 8),\n",
       " (('due', 'funding', 'issues'), 8),\n",
       " (('withdrawn', 'withdrawn', 'withdrawn'), 8),\n",
       " (('study', 'unable', 'recruit'), 8),\n",
       " (('recruit', 'enough', 'patients'), 8),\n",
       " (('fda', 'clinical', 'hold'), 8),\n",
       " (('slow', 'patient', 'recruitment'), 8),\n",
       " (('patient', 'accrual', 'low'), 8),\n",
       " (('low', 'enrollment', 'due'), 8),\n",
       " (('serious', 'adverse', 'events'), 8),\n",
       " (('recruit', 'unable', 'recruit'), 8),\n",
       " (('study', 'due', 'lack'), 8),\n",
       " (('patients', 'unable', 'enroll'), 8),\n",
       " (('unable', 'enroll', 'unable'), 8),\n",
       " (('terminated', 'early', 'based'), 8),\n",
       " (('patient', 'enrollment', 'study'), 8),\n",
       " (('terminated', 'business', 'reasons'), 8),\n",
       " (('patients', 'study', 'terminated'), 8),\n",
       " (('lack', 'enrollment', 'study'), 8),\n",
       " (('protocol', 'study', 'terminated'), 8),\n",
       " (('related', 'safety', 'efficacy'), 8),\n",
       " (('stopped', 'due', 'insufficient'), 8),\n",
       " (('study', 'stopped', 'sponsor'), 8),\n",
       " (('non', 'safety', 'related'), 8),\n",
       " (('study', 'cancelled', 'study'), 8),\n",
       " (('patient', 'recruitment', 'study'), 8),\n",
       " (('decision', 'discontinue', 'study'), 8),\n",
       " (('lack', 'recruitment', 'study'), 8),\n",
       " (('study', 'due', 'slow'), 8),\n",
       " (('lack', 'patient', 'accrual'), 8),\n",
       " (('study', 'halted', 'due'), 8),\n",
       " (('sponsor', 'decided', 'stop'), 8),\n",
       " (('study', 'principal', 'investigator'), 8),\n",
       " (('principal', 'investigator', 'decided'), 8),\n",
       " (('halted', 'due', 'covid'), 8),\n",
       " (('pi', 'decided', 'close'), 8),\n",
       " (('drug', 'longer', 'available'), 8),\n",
       " (('change', 'benefit', 'risk'), 8),\n",
       " (('futility', 'interim', 'analysis'), 8),\n",
       " (('investigator', 'left', 'university'), 8),\n",
       " (('first', 'participant', 'study'), 8),\n",
       " (('participant', 'study', 'halted'), 8),\n",
       " (('slow', 'insufficient', 'accrual'), 8),\n",
       " (('unrelated', 'safety', 'efficacy'), 8),\n",
       " (('decision', 'unrelated', 'safety'), 8),\n",
       " (('scheduled', 'interim', 'monitoring'), 8),\n",
       " (('stopped', 'study', 'safety'), 8),\n",
       " (('study', 'safety', 'fda'), 8),\n",
       " (('safety', 'fda', 'put'), 8),\n",
       " (('fda', 'put', 'study'), 8),\n",
       " (('decision', 'pi', 'decision'), 8),\n",
       " (('enrolled', 'subjects', 'enrolled'), 8),\n",
       " (('obtained', 'funding', 'obtained'), 8),\n",
       " (('rate', 'low', 'inclusion'), 8),\n",
       " (('low', 'accrual', 'due'), 8),\n",
       " (('lack', 'subject', 'enrollment'), 8),\n",
       " (('resources', 'lack', 'resources'), 8),\n",
       " (('subjects', 'inability', 'recruit'), 8),\n",
       " (('inability', 'enroll', 'subjects'), 8),\n",
       " (('difficult', 'recruitment', 'difficult'), 8),\n",
       " (('slow', 'accrual', 'closed'), 8),\n",
       " (('due', 'lack', 'resources'), 7),\n",
       " (('recruitment', 'difficulties', 'study'), 7),\n",
       " (('due', 'inability', 'recruit'), 7),\n",
       " (('unable', 'enroll', 'participants'), 7),\n",
       " (('recruitment', 'poor', 'patient'), 7),\n",
       " (('due', 'covid', 'restrictions'), 7),\n",
       " (('recruit', 'subjects', 'unable'), 7),\n",
       " (('funding', 'period', 'ended'), 7),\n",
       " (('unable', 'recruit', 'adequate'), 7),\n",
       " (('recruit', 'adequate', 'number'), 7),\n",
       " (('participants', 'unable', 'enroll'), 7),\n",
       " (('enroll', 'patients', 'study'), 7),\n",
       " (('enroll', 'unable', 'enroll'), 7),\n",
       " (('strategic', 'business', 'decision'), 7),\n",
       " (('enrollment', 'study', 'withdrawn'), 7),\n",
       " (('terminated', 'due', 'safety'), 7),\n",
       " (('poor', 'recruitment', 'study'), 7),\n",
       " (('lack', 'efficacy', 'based'), 7),\n",
       " (('due', 'insufficient', 'recruitment'), 7),\n",
       " (('study', 'study', 'stopped'), 7),\n",
       " (('study', 'stopped', 'prematurely'), 7),\n",
       " (('stopped', 'prematurely', 'due'), 7),\n",
       " (('enrolled', 'study', 'never'), 7),\n",
       " (('primary', 'endpoint', 'study'), 7),\n",
       " (('study', 'terminated', 'study'), 7),\n",
       " (('pandemic', 'study', 'terminated'), 7),\n",
       " (('pre', 'planned', 'interim'), 7),\n",
       " (('study', 'closed', 'accrual'), 7),\n",
       " (('business', 'reasons', 'safety'), 7),\n",
       " (('slow', 'accrual', 'rate'), 7),\n",
       " (('terminated', 'sponsor', 'study'), 7),\n",
       " (('business', 'decision', 'study'), 7),\n",
       " (('institution', 'study', 'terminated'), 7),\n",
       " (('patients', 'study', 'stopped'), 7),\n",
       " (('slow', 'patient', 'accrual'), 7),\n",
       " (('prematurely', 'discontinued', 'due'), 7),\n",
       " (('suspended', 'due', 'pandemic'), 7),\n",
       " (('decided', 'move', 'forward'), 7),\n",
       " (('slower', 'anticipated', 'enrollment'), 7),\n",
       " (('hold', 'due', 'covid'), 7),\n",
       " (('study', 'due', 'poor'), 7),\n",
       " (('termination', 'study', 'due'), 7),\n",
       " (('decided', 'withdraw', 'study'), 7),\n",
       " (('primary', 'endpoint', 'met'), 7),\n",
       " (('longer', 'work', 'hadassah'), 7),\n",
       " (('work', 'hadassah', 'pi'), 7),\n",
       " (('close', 'study', 'due'), 7),\n",
       " (('sponsor', 'decision', 'discontinue'), 7),\n",
       " (('per', 'pi', 'request'), 7),\n",
       " (('recruitment', 'terminated', 'due'), 7),\n",
       " (('reasons', 'unrelated', 'safety'), 7),\n",
       " (('pandemic', 'temporarily', 'suspended'), 7),\n",
       " (('enrolled', 'study', 'withdrawn'), 7),\n",
       " (('reasons', 'safety', 'reasons'), 7),\n",
       " (('accrual', 'goal', 'met'), 7),\n",
       " (('study', 'sponsor', 'terminated'), 7),\n",
       " (('safety', 'concerns', 'identified'), 7),\n",
       " (('study', 'completed', 'study'), 7),\n",
       " (('slow', 'inclusion', 'rate'), 7),\n",
       " (('sponsor', 'discretion', 'sponsor'), 7),\n",
       " (('closed', 'study', 'due'), 7),\n",
       " (('interim', 'monitoring', 'scheduled'), 7),\n",
       " (('monitoring', 'scheduled', 'interim'), 7),\n",
       " (('safety', 'reasons', 'safety'), 7),\n",
       " (('study', 'hold', 'safety'), 7),\n",
       " (('hold', 'safety', 'repros'), 7),\n",
       " (('safety', 'repros', 'stopped'), 7),\n",
       " (('investigator', 'leaving', 'institution'), 7),\n",
       " (('interim', 'analysis', 'indicated'), 7),\n",
       " (('poor', 'patient', 'accrual'), 7),\n",
       " (('pi', 'left', 'jhu'), 7),\n",
       " (('pi', 'left', 'pi'), 7),\n",
       " (('subjects', 'enrolled', 'subjects'), 7),\n",
       " (('subject', 'enrollment', 'lack'), 7),\n",
       " (('lack', 'participants', 'lack'), 7),\n",
       " (('inability', 'recruit', 'subjects'), 7),\n",
       " (('recruiting', 'subjects', 'difficulty'), 7),\n",
       " (('participants', 'difficulty', 'recruiting'), 7),\n",
       " (('recruitment', 'difficult', 'recruitment'), 7),\n",
       " (('study', 'withdrawn', 'irb'), 6),\n",
       " (('never', 'opened', 'accrual'), 6),\n",
       " (('withdrawn', 'participants', 'enrolled'), 6),\n",
       " (('enroll', 'enough', 'participants'), 6),\n",
       " (('funding', 'support', 'study'), 6),\n",
       " (('accrual', 'low', 'patient'), 6),\n",
       " (('within', 'reasonable', 'time'), 6),\n",
       " (('number', 'patients', 'unable'), 6),\n",
       " (('recruit', 'participants', 'unable'), 6),\n",
       " (('meet', 'recruitment', 'goals'), 6),\n",
       " (('meet', 'enrollment', 'goals'), 6),\n",
       " (('patients', 'meeting', 'inclusion'), 6),\n",
       " (('subjects', 'unable', 'enroll'), 6),\n",
       " (('unable', 'enroll', 'subjects'), 6),\n",
       " (('study', 'due', 'covid'), 6),\n",
       " (('terminated', 'early', 'per'), 6),\n",
       " (('due', 'safety', 'efficacy'), 6),\n",
       " (('efficacy', 'data', 'another'), 6),\n",
       " (('recruitment', 'lack', 'funding'), 6),\n",
       " (('terminated', 'dec', 'due'), 6),\n",
       " (('due', 'poor', 'patient'), 6),\n",
       " (('withdrawn', 'prior', 'enrollment'), 6),\n",
       " (('prior', 'enrollment', 'study'), 6),\n",
       " (('terminated', 'prematurely', 'sponsor'), 6),\n",
       " (('issues', 'study', 'terminated'), 6),\n",
       " (('low', 'patient', 'enrollment'), 6),\n",
       " (('slow', 'accrual', 'patients'), 6),\n",
       " (('due', 'recruitment', 'difficulties'), 6),\n",
       " (('participants', 'study', 'terminated'), 6),\n",
       " (('terminated', 'due', 'inability'), 6),\n",
       " (('inability', 'recruit', 'sufficient'), 6),\n",
       " (('prematurely', 'due', 'low'), 6),\n",
       " (('corporate', 'decision', 'study'), 6),\n",
       " (('decision', 'study', 'stopped'), 6),\n",
       " (('terminated', 'june', 'due'), 6),\n",
       " (('study', 'prematurely', 'discontinued'), 6),\n",
       " (('study', 'closed', 'prematurely'), 6),\n",
       " (('cancelled', 'study', 'cancelled'), 6),\n",
       " (('decision', 'related', 'safety'), 6),\n",
       " (('another', 'study', 'study'), 6),\n",
       " (('sars', 'cov', 'pandemic'), 6),\n",
       " (('based', 'safety', 'concerns'), 6),\n",
       " (('decision', 'study', 'withdrawn'), 6),\n",
       " (('based', 'new', 'efficacy'), 6),\n",
       " (('new', 'efficacy', 'data'), 6),\n",
       " (('data', 'another', 'study'), 6),\n",
       " (('prematurely', 'due', 'slow'), 6),\n",
       " (('safety', 'reasons', 'study'), 6),\n",
       " (('interim', 'analysis', 'futility'), 6),\n",
       " (('lack', 'efficacy', 'interim'), 6),\n",
       " (('due', 'enrollment', 'challenges'), 6),\n",
       " (('resources', 'complete', 'study'), 6),\n",
       " (('study', 'terminated', 'pi'), 6),\n",
       " (('concerns', 'study', 'stopped'), 6),\n",
       " (('funding', 'study', 'stopped'), 6),\n",
       " (('study', 'activated', 'study'), 6),\n",
       " (('early', 'terminated', 'due'), 6),\n",
       " (('efficacy', 'study', 'stopped'), 6),\n",
       " (('stopped', 'due', 'covid'), 6),\n",
       " (('business', 'reasons', 'sponsor'), 6),\n",
       " (('early', 'termination', 'study'), 6),\n",
       " (('enable', 'registration', 'duvelisib'), 6),\n",
       " (('pi', 'longer', 'work'), 6),\n",
       " (('hadassah', 'pi', 'longer'), 6),\n",
       " (('study', 'meet', 'primary'), 6),\n",
       " (('interim', 'analysis', 'suggested'), 6),\n",
       " (('stop', 'trial', 'based'), 6),\n",
       " (('based', 'efficacy', 'results'), 6),\n",
       " (('decided', 'stop', 'development'), 6),\n",
       " (('interim', 'analysis', 'results'), 6),\n",
       " (('terminated', 'recruiting', 'enrolling'), 6),\n",
       " (('sponsor', 'decision', 'terminated'), 6),\n",
       " (('lack', 'enrollment', 'terminated'), 6),\n",
       " (('sponsor', 'terminated', 'due'), 6),\n",
       " (('investigator', 'left', 'nih'), 6),\n",
       " (('low', 'accrual', 'terminated'), 6),\n",
       " (('funding', 'terminated', 'due'), 6),\n",
       " (('due', 'pandemic', 'temporarily'), 6),\n",
       " (('never', 'opened', 'study'), 6),\n",
       " (('opened', 'study', 'never'), 6),\n",
       " (('another', 'study', 'new'), 6),\n",
       " (('halted', 'prematurely', 'potentially'), 6),\n",
       " (('prematurely', 'potentially', 'resume'), 6),\n",
       " (('longer', 'examined', 'receiving'), 6),\n",
       " (('examined', 'receiving', 'intervention'), 6),\n",
       " (('completed', 'study', 'completed'), 6),\n",
       " (('analysis', 'interim', 'analysis'), 6),\n",
       " (('decision', 'withdraw', 'study'), 6),\n",
       " (('support', 'sponsor', 'withdrew'), 6),\n",
       " (('sponsor', 'request', 'sponsor'), 6),\n",
       " (('discretion', 'sponsor', 'discretion'), 6),\n",
       " (('decision', 'due', 'low'), 6),\n",
       " (('discontinue', 'study', 'drug'), 6),\n",
       " (('study', 'drug', 'development'), 6),\n",
       " (('drug', 'development', 'sponsor'), 6),\n",
       " (('development', 'sponsor', 'decided'), 6),\n",
       " (('changes', 'standard', 'care'), 6),\n",
       " (('slow', 'inclusion', 'slow'), 6),\n",
       " (('inclusion', 'slow', 'inclusion'), 6),\n",
       " (('termination', 'reason', 'see'), 6),\n",
       " (('reason', 'see', 'detailed'), 6),\n",
       " (('monitoring', 'committee', 'recommendation'), 6),\n",
       " (('principle', 'investigator', 'left'), 6),\n",
       " (('left', 'institution', 'prior'), 6),\n",
       " (('patient', 'recruitment', 'poor'), 6),\n",
       " (('pi', 'left', 'university'), 6),\n",
       " (('left', 'pi', 'left'), 6),\n",
       " (('funding', 'longer', 'available'), 6),\n",
       " (('enough', 'recruitment', 'enough'), 6),\n",
       " (('patient', 'enrollment', 'lack'), 6),\n",
       " (('recruited', 'patients', 'recruited'), 6),\n",
       " (('low', 'patient', 'accrual'), 6),\n",
       " (('logistics', 'logistics', 'logistics'), 6),\n",
       " (('enrollment', 'lack', 'subject'), 6),\n",
       " (('patient', 'accrual', 'lack'), 6),\n",
       " (('accrual', 'lack', 'patient'), 6),\n",
       " (('participants', 'lack', 'participants'), 6),\n",
       " (('investigator', 'choice', 'investigator'), 6),\n",
       " (('groups', 'interim', 'analysis'), 6),\n",
       " (('interim', 'analysis', 'revealed'), 6),\n",
       " (('interim', 'analysis', 'interim'), 6),\n",
       " (('insufficient', 'number', 'participants'), 6),\n",
       " (('inadequate', 'accrual', 'rate'), 6),\n",
       " (('accrual', 'rate', 'inadequate'), 6),\n",
       " (('rate', 'inadequate', 'accrual'), 6),\n",
       " (('number', 'patients', 'inability'), 6),\n",
       " (('recruit', 'subjects', 'inability'), 6),\n",
       " (('recruit', 'patients', 'inability'), 6),\n",
       " (('difficulty', 'patient', 'recruitment'), 6),\n",
       " (('funding', 'terminated', 'funding'), 6),\n",
       " (('received', 'funding', 'received'), 6),\n",
       " (('hold', 'fda', 'clinical'), 6),\n",
       " (('enrollment', 'temporarily', 'paused'), 6),\n",
       " (('enrollment', 'interactions', 'interventions'), 6),\n",
       " (('overall', 'benefit', 'risk'), 6),\n",
       " (('difficulty', 'enrolling', 'subjects'), 6),\n",
       " (('subjects', 'difficulty', 'enrolling'), 6),\n",
       " (('competing', 'studies', 'competing'), 6),\n",
       " (('company', 'decision', 'discontinue'), 6),\n",
       " (('business', 'decision', 'stop'), 6),\n",
       " (('decision', 'stop', 'program'), 6),\n",
       " (('stop', 'program', 'business'), 6),\n",
       " (('program', 'business', 'decision'), 6),\n",
       " (('withdrawn', 'study', 'withdrawn'), 5),\n",
       " (('withdrawn', 'due', 'slow'), 5),\n",
       " (('withdrawn', 'due', 'poor'), 5),\n",
       " (('low', 'accrual', 'withdrawn'), 5),\n",
       " (('due', 'change', 'standard'), 5),\n",
       " (('due', 'safety', 'reasons'), 5),\n",
       " (('study', 'unable', 'enroll'), 5),\n",
       " (('recruit', 'enough', 'participants'), 5),\n",
       " (('required', 'number', 'patients'), 5),\n",
       " (('due', 'interim', 'analysis'), 5),\n",
       " (('decided', 'pursue', 'study'), 5),\n",
       " (('stop', 'study', 'due'), 5),\n",
       " (('unable', 'obtain', 'funding'), 5),\n",
       " (('failed', 'meet', 'primary'), 5),\n",
       " (('low', 'rate', 'recruitment'), 5),\n",
       " (('difficulty', 'recruiting', 'study'), 5),\n",
       " (('enough', 'patients', 'unable'), 5),\n",
       " (('adequate', 'number', 'patients'), 5),\n",
       " (('enroll', 'patients', 'unable'), 5),\n",
       " (('enroll', 'enough', 'subjects'), 5),\n",
       " (('decision', 'trial', 'terminated'), 5),\n",
       " (('interim', 'futility', 'analysis'), 5),\n",
       " (('treatment', 'ineffective', 'treatment'), 5),\n",
       " (('sponsor', 'decided', 'terminate'), 5),\n",
       " (('prematurely', 'terminated', 'dec'), 5),\n",
       " (('dec', 'due', 'safety'), 5),\n",
       " (('safety', 'concerns', 'specifically'), 5),\n",
       " (('emerging', 'evidence', 'hepatic'), 5),\n",
       " (('evidence', 'hepatic', 'injury'), 5),\n",
       " (('reasons', 'safety', 'concerns'), 5),\n",
       " (('withdrawn', 'due', 'business'), 5),\n",
       " (('study', 'terminated', 'business'), 5),\n",
       " (('terminated', 'administrative', 'reasons'), 5),\n",
       " (('insufficient', 'recruitment', 'study'), 5),\n",
       " (('terminated', 'early', 'result'), 5),\n",
       " (('challenges', 'study', 'terminated'), 5),\n",
       " (('study', 'design', 'study'), 5),\n",
       " (('design', 'study', 'terminated'), 5),\n",
       " (('study', 'never', 'funded'), 5),\n",
       " (('low', 'recruitment', 'study'), 5),\n",
       " (('closed', 'prematurely', 'due'), 5),\n",
       " (('safety', 'concern', 'study'), 5),\n",
       " (('enrolling', 'participants', 'due'), 5),\n",
       " (('study', 'terminated', 'result'), 5),\n",
       " (('study', 'replaced', 'another'), 5),\n",
       " (('study', 'cancelled', 'prior'), 5),\n",
       " (('long', 'term', 'follow'), 5),\n",
       " (('meet', 'pre', 'specified'), 5),\n",
       " (('study', 'study', 'withdrawn'), 5),\n",
       " (('terminated', 'per', 'pi'), 5),\n",
       " (('study', 'terminated', 'june'), 5),\n",
       " (('termination', 'due', 'safety'), 5),\n",
       " (('study', 'terminated', 'lack'), 5),\n",
       " (('difficulties', 'patient', 'recruitment'), 5),\n",
       " (('early', 'due', 'business'), 5),\n",
       " (('terminated', 'early', 'sponsor'), 5),\n",
       " (('safety', 'issues', 'study'), 5),\n",
       " (('phase', 'iii', 'study'), 5),\n",
       " (('subjects', 'study', 'terminated'), 5),\n",
       " (('study', 'terminated', 'low'), 5),\n",
       " (('original', 'principal', 'investigator'), 5),\n",
       " (('principal', 'investigator', 'moved'), 5),\n",
       " (('investigator', 'moved', 'new'), 5),\n",
       " (('trial', 'study', 'stopped'), 5),\n",
       " (('due', 'slow', 'patient'), 5),\n",
       " (('activated', 'study', 'activated'), 5),\n",
       " (('patients', 'enrolled', 'due'), 5),\n",
       " (('funding', 'study', 'halted'), 5),\n",
       " (('study', 'ended', 'early'), 5),\n",
       " (('study', 'early', 'terminated'), 5),\n",
       " (('due', 'non', 'safety'), 5),\n",
       " (('study', 'study', 'closed'), 5),\n",
       " (('due', 'budget', 'limitations'), 5),\n",
       " (('reasons', 'study', 'stopped'), 5),\n",
       " (('study', 'design', 'changed'), 5),\n",
       " (('decided', 'end', 'study'), 5),\n",
       " (('sponsor', 'stopped', 'study'), 5),\n",
       " (('study', 'sponsor', 'decided'), 5),\n",
       " (('decision', 'discontinue', 'development'), 5),\n",
       " (('primary', 'endpoint', 'reached'), 5),\n",
       " (('recommended', 'stopping', 'study'), 5),\n",
       " (('dose', 'limiting', 'toxicity'), 5),\n",
       " (('decision', 'stop', 'trial'), 5),\n",
       " (('trial', 'based', 'efficacy'), 5),\n",
       " (('efficacy', 'results', 'overall'), 5),\n",
       " (('results', 'overall', 'schizophrenia'), 5),\n",
       " (('population', 'decision', 'stop'), 5),\n",
       " (('decision', 'stop', 'study'), 5),\n",
       " (('slow', 'patient', 'enrollment'), 5),\n",
       " (('safety', 'concerns', 'due'), 5),\n",
       " (('early', 'sponsor', 'decision'), 5),\n",
       " (('low', 'enrollment', 'terminated'), 5),\n",
       " (('terminated', 'due', 'sponsor'), 5),\n",
       " (('closed', 'accrual', 'due'), 5),\n",
       " (('suspended', 'due', 'lack'), 5),\n",
       " (('per', 'sponsor', 'decision'), 5),\n",
       " (('study', 'withdrawn', 'participants'), 5),\n",
       " (('leaving', 'institution', 'study'), 5),\n",
       " (('business', 'decision', 'due'), 5),\n",
       " (('enrolled', 'study', 'terminated'), 5),\n",
       " (('study', 'started', 'study'), 5),\n",
       " (('initiated', 'study', 'initiated'), 5),\n",
       " (('discontinued', 'due', 'lack'), 5),\n",
       " (('business', 'decision', 'discontinue'), 5),\n",
       " (('phase', 'ii', 'study'), 5),\n",
       " (('low', 'enrolment', 'rate'), 5),\n",
       " (('study', 'pi', 'left'), 5),\n",
       " (('financial', 'support', 'study'), 5),\n",
       " (('irb', 'approval', 'expired'), 5),\n",
       " (('resume', 'study', 'halted'), 5),\n",
       " (('strategic', 'decision', 'unrelated'), 5),\n",
       " (('drug', 'supply', 'issues'), 5),\n",
       " (('interim', 'analysis', 'primary'), 5),\n",
       " (('change', 'clinical', 'strategy'), 5),\n",
       " (('study', 'design', 'change'), 5),\n",
       " (('accrual', 'due', 'low'), 5),\n",
       " (('accrual', 'rate', 'slow'), 5),\n",
       " (('decision', 'made', 'terminate'), 5),\n",
       " (('withdrew', 'support', 'sponsor'), 5),\n",
       " (('terminated', 'study', 'sponsor'), 5),\n",
       " (('request', 'sponsor', 'request'), 5),\n",
       " (('funding', 'low', 'accrual'), 5),\n",
       " (('safety', 'sponsor', 'decision'), 5),\n",
       " (('sponsor', 'closed', 'study'), 5),\n",
       " (('sponsor', 'business', 'decision'), 5),\n",
       " (('insufficient', 'accrual', 'slow'), 5),\n",
       " (('accrual', 'slow', 'insufficient'), 5),\n",
       " (('slow', 'accruals', 'slow'), 5),\n",
       " (('difficulty', 'enrolling', 'patients'), 5),\n",
       " (('primary', 'investigator', 'left'), 5),\n",
       " (('recruiting', 'problems', 'recruiting'), 5),\n",
       " (('examined', 'treated', 'recruiting'), 5),\n",
       " (('treated', 'recruiting', 'enrolling'), 5),\n",
       " (('meeting', 'inclusion', 'criteria'), 5),\n",
       " (('moved', 'another', 'institution'), 5),\n",
       " (('institution', 'principle', 'investigator'), 5),\n",
       " (('primary', 'investigator', 'longer'), 5),\n",
       " (('accrual', 'poor', 'patient'), 5),\n",
       " (('patient', 'accrual', 'poor'), 5),\n",
       " (('enrollment', 'pi', 'left'), 5),\n",
       " (('reasonable', 'time', 'frame'), 5),\n",
       " (('left', 'university', 'pi'), 5),\n",
       " (('university', 'pi', 'left'), 5),\n",
       " (('study', 'pi', 'decided'), 5),\n",
       " (('number', 'eligible', 'patients'), 5),\n",
       " (('recruitment', 'enough', 'recruitment'), 5),\n",
       " (('patients', 'could', 'recruited'), 5),\n",
       " (('subjects', 'enrolled', 'funding'), 5),\n",
       " (('recruitment', 'due', 'covid'), 5),\n",
       " (('patients', 'recruited', 'patients'), 5),\n",
       " (('participant', 'enrolled', 'participant'), 5),\n",
       " (('financial', 'support', 'financial'), 5),\n",
       " (('eligible', 'patient', 'enrolled'), 5),\n",
       " (('patient', 'enrolled', 'eligible'), 5),\n",
       " (('study', 'new', 'data'), 5),\n",
       " (('new', 'data', 'study'), 5),\n",
       " (('terminated', 'based', 'new'), 5),\n",
       " (('negative', 'efficacy', 'results'), 5),\n",
       " (('recently', 'completed', 'phase'), 5),\n",
       " (('funding', 'lost', 'funding'), 5),\n",
       " (('patient', 'population', 'lack'), 5),\n",
       " (('lack', 'recruitement', 'lack'), 5),\n",
       " (('lack', 'patient', 'enrollment'), 5),\n",
       " (('enrollment', 'lack', 'patient'), 5),\n",
       " (('lack', 'inclusion', 'lack'), 5),\n",
       " (('study', 'lack', 'funding'), 5),\n",
       " (('eligible', 'patients', 'lack'), 5),\n",
       " (('patients', 'lack', 'eligible'), 5),\n",
       " (('analysis', 'lack', 'efficacy'), 5),\n",
       " (('difficult', 'recruit', 'participants'), 5),\n",
       " (('choice', 'investigator', 'choice'), 5),\n",
       " (('insufficient', 'staff', 'insufficient'), 5),\n",
       " (('study', 'insufficient', 'resources'), 5),\n",
       " (('complete', 'study', 'insufficient'), 5),\n",
       " (('insufficient', 'recruitment', 'rate'), 5),\n",
       " (('recruitment', 'rate', 'insufficient'), 5),\n",
       " (('rate', 'insufficient', 'recruitment'), 5),\n",
       " (('inadequate', 'patient', 'recruitment'), 5),\n",
       " (('enroll', 'subjects', 'inability'), 5),\n",
       " (('subjects', 'inability', 'enroll'), 5),\n",
       " (('funding', 'discontinued', 'funding'), 5),\n",
       " (('funding', 'issue', 'funding'), 5),\n",
       " (('following', 'recommendation', 'solar'), 5),\n",
       " (('recommendation', 'solar', 'study'), 5),\n",
       " (('solar', 'study', 'idmc'), 5),\n",
       " (('study', 'idmc', 'astellas'), 5),\n",
       " (('idmc', 'astellas', 'closed'), 5),\n",
       " (('astellas', 'closed', 'enrollment'), 5),\n",
       " (('closed', 'enrollment', 'asp'), 5),\n",
       " (('enrollment', 'asp', 'studies'), 5),\n",
       " (('asp', 'studies', 'following'), 5),\n",
       " (('financial', 'assistance', 'financial'), 5),\n",
       " (('feasibility', 'issues', 'feasibility'), 5),\n",
       " (('feasibility', 'feasibility', 'feasibility'), 5),\n",
       " (('participants', 'failure', 'recruit'), 5),\n",
       " (('enrollment', 'closed', 'due'), 5),\n",
       " (('approval', 'enrollment', 'interactions'), 5),\n",
       " (('interactions', 'interventions', 'paused'), 5),\n",
       " (('interventions', 'paused', 'due'), 5),\n",
       " (('recruitment', 'early', 'termination'), 5),\n",
       " (('withdraw', 'study', 'due'), 5),\n",
       " (('liver', 'safety', 'see'), 5),\n",
       " (('safety', 'see', 'detailed'), 5),\n",
       " (('detailed', 'description', 'due'), 5),\n",
       " (('longer', 'available', 'drug'), 5),\n",
       " (('covid', 'restrictions', 'covid'), 5),\n",
       " (('corporate', 'decision', 'corporate'), 5),\n",
       " (('decision', 'corporate', 'decision'), 5),\n",
       " (('studies', 'competing', 'studies'), 5),\n",
       " (('trial', 'company', 'decision'), 5),\n",
       " (('strategy', 'change', 'clinical'), 5),\n",
       " (('az', 'decision', 'discontinue'), 5),\n",
       " (('decision', 'discontinue', 'fostamatinib'), 5),\n",
       " (('discontinue', 'fostamatinib', 'development'), 5),\n",
       " (('fostamatinib', 'development', 'ra'), 5),\n",
       " (('development', 'ra', 'rights'), 5),\n",
       " (('ra', 'rights', 'fostamatinib'), 5),\n",
       " (('rights', 'fostamatinib', 'returned'), 5),\n",
       " (('fostamatinib', 'returned', 'rigel'), 5),\n",
       " (('returned', 'rigel', 'pharmaceuticals'), 5),\n",
       " (('reason', 'reason', 'reason'), 4),\n",
       " (('withdrawn', 'administrative', 'reasons'), 4),\n",
       " (('funding', 'withdrawn', 'due'), 4),\n",
       " (('withdrawn', 'due', 'low'), 4),\n",
       " (('withdrawn', 'due', 'change'), 4),\n",
       " (('change', 'standard', 'care'), 4),\n",
       " (('study', 'due', 'safety'), 4),\n",
       " (('covid', 'restrictions', 'prevent'), 4),\n",
       " (('restrictions', 'prevent', 'patient'), 4),\n",
       " (('prevent', 'patient', 'enrollment'), 4),\n",
       " (('patient', 'enrollment', 'treatment'), 4),\n",
       " (('enrollment', 'treatment', 'clinical'), 4),\n",
       " (('treatment', 'clinical', 'trial'), 4),\n",
       " (('clinical', 'trial', 'facility'), 4),\n",
       " (('trial', 'facility', 'closed'), 4),\n",
       " (('facility', 'closed', 'due'), 4),\n",
       " (('closed', 'due', 'viral'), 4),\n",
       " (('due', 'viral', 'limitations'), 4),\n",
       " (('viral', 'limitations', 'loss'), 4),\n",
       " (('limitations', 'loss', 'staff'), 4),\n",
       " (('loss', 'staff', 'perform'), 4),\n",
       " (('able', 'recruit', 'participants'), 4),\n",
       " (('funding', 'complete', 'study'), 4),\n",
       " (('difficulties', 'recruiting', 'subjects'), 4),\n",
       " (('new', 'study', 'design'), 4),\n",
       " (('could', 'complete', 'study'), 4),\n",
       " (('data', 'analysis', 'completed'), 4),\n",
       " (('low', 'patient', 'recruitment'), 4),\n",
       " (('enrollment', 'due', 'low'), 4),\n",
       " (('difficult', 'recruit', 'patients'), 4),\n",
       " (('liver', 'function', 'tests'), 4),\n",
       " (('unique', 'provision', 'american'), 4),\n",
       " (('provision', 'american', 'recovery'), 4),\n",
       " (('american', 'recovery', 'reinvestment'), 4),\n",
       " (('recovery', 'reinvestment', 'act'), 4),\n",
       " (('reinvestment', 'act', 'prevented'), 4),\n",
       " (('act', 'prevented', 'approval'), 4),\n",
       " (('prevented', 'approval', 'second'), 4),\n",
       " (('approval', 'second', 'year'), 4),\n",
       " (('second', 'year', 'cost'), 4),\n",
       " (('year', 'cost', 'extension'), 4),\n",
       " (('cost', 'extension', 'completion'), 4),\n",
       " (('extension', 'completion', 'analyses'), 4),\n",
       " (('completion', 'analyses', 'planned'), 4),\n",
       " (('high', 'drop', 'rate'), 4),\n",
       " (('recruit', 'sufficient', 'participants'), 4),\n",
       " (('unable', 'recruit', 'due'), 4),\n",
       " (('recruit', 'due', 'covid'), 4),\n",
       " (('unable', 'meet', 'enrollment'), 4),\n",
       " (('enrollment', 'goals', 'unable'), 4),\n",
       " (('willing', 'participate', 'study'), 4),\n",
       " (('enroll', 'subjects', 'unable'), 4),\n",
       " (('unable', 'enroll', 'enough'), 4),\n",
       " (('enrollment', 'due', 'lack'), 4),\n",
       " (('complete', 'enrollment', 'due'), 4),\n",
       " (('device', 'used', 'study'), 4),\n",
       " (('unable', 'accrue', 'subjects'), 4),\n",
       " (('early', 'per', 'business'), 4),\n",
       " (('per', 'business', 'decision'), 4),\n",
       " (('business', 'decision', 'trial'), 4),\n",
       " (('due', 'company', 'decision'), 4),\n",
       " (('efficacy', 'safety', 'concerns'), 4),\n",
       " (('efficacy', 'based', 'results'), 4),\n",
       " (('study', 'protocol', 'study'), 4),\n",
       " (('difficulties', 'study', 'terminated'), 4),\n",
       " (('study', 'site', 'study'), 4),\n",
       " (('terminated', 'due', 'failure'), 4),\n",
       " (('subject', 'accrual', 'study'), 4),\n",
       " (('study', 'stopped', 'slow'), 4),\n",
       " (('data', 'collected', 'study'), 4),\n",
       " (('study', 'closed', 'recruitment'), 4),\n",
       " (('recruitment', 'study', 'closed'), 4),\n",
       " (('study', 'closed', 'enrollment'), 4),\n",
       " (('efficacy', 'concerns', 'study'), 4),\n",
       " (('due', 'corporate', 'decision'), 4),\n",
       " (('study', 'closed', 'prior'), 4),\n",
       " (('receive', 'irb', 'approval'), 4),\n",
       " (('never', 'started', 'due'), 4),\n",
       " (('closed', 'enrollment', 'due'), 4),\n",
       " (('due', 'lack', 'study'), 4),\n",
       " (('study', 'permanently', 'closed'), 4)]"
      ]
     },
     "execution_count": 45,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "fd=FreqDist(n_grams)\n",
    "fd.most_common(1000)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [],
   "source": [
    "reasons={\n",
    "    'Insufficient Enrollment':['enrol','recruit','inclusion','candidate','subject','patient','participa'],\n",
    "    'Due to COVID':['pandemic','covid'],\n",
    "    'Interim analysis':['interim'],\n",
    "    'Slow Accural':['accural','accrual'],\n",
    "    'Lack of efficacy':['efficacy'],\n",
    "    'Early Termination Date':['early'],\n",
    "    'Pricipal Investigator Left':['investigator'],\n",
    "    'Funding':['fund','financ'],\n",
    "    'Preliminary':['preliminary'],\n",
    "    'Company Decision(s)':['decision', 'administra', 'company'],\n",
    "    'Technical Issues':['technical', 'issue'],\n",
    "    'Insufficient data':['data',],\n",
    "    'Safety Concern':['safety', 'adverse', 'health'],\n",
    "    'Study Not Started':['not started'],\n",
    "    'No Reason Stated':['not stated'],\n",
    "    'Halted Prematurely':['prematurely'],\n",
    "    'Other':['descript','acquisition','reason']\n",
    "}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [],
   "source": [
    "data_reasons=dict()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [],
   "source": [
    "for reason in reasons.keys():\n",
    "    data_reasons[reason]=np.zeros(len(dataset))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [],
   "source": [
    "for index in range(len(dataset)):\n",
    "    sent=dataset.loc[index,'why_stopped']\n",
    "    if type(sent)!=float:\n",
    "        for word in r.tokenize(sent.lower()):\n",
    "            for reason in reasons.keys():\n",
    "                for val in reasons[reason]:\n",
    "                    if word.find(val)==0:\n",
    "                        data_reasons[reason][index]=1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [],
   "source": [
    "data_reasons=pd.DataFrame(data_reasons)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\carol\\anaconda3\\lib\\site-packages\\seaborn\\_decorators.py:36: FutureWarning: Pass the following variables as keyword args: x, y. From version 0.12, the only valid positional argument will be `data`, and passing other arguments without an explicit keyword will result in an error or misinterpretation.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<AxesSubplot:title={'center':'Clincal Trials Stopped Reason'}>"
      ]
     },
     "execution_count": 51,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 720x720 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(10,10))\n",
    "plt.xticks(rotation=90)\n",
    "plt.title('Clincal Trials Stopped Reason')\n",
    "sns.barplot(data_reasons.sum().index,data_reasons.sum().values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": [
    "categories={\n",
    "    'Neutral':['Insufficient Enrollment','Pricipal Investigator Left','Preliminary','Other', 'Study Not Started',\n",
    "               'Due to COVID', 'Early Termination Date', 'Interim analysis'],\n",
    "    'Possibly Negative':['Slow Accural','Company Decision(s)','Funding', 'Lack of efficacy', 'Insufficient data'],\n",
    "    'Negative Efficacy':['Technical Issues', 'Safety Concern']\n",
    "}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [],
   "source": [
    "data_categories=dict()\n",
    "counts=data_reasons.sum()\n",
    "for category in categories.keys():\n",
    "    data_categories[category]=0\n",
    "for category in categories.keys():\n",
    "    c=0;\n",
    "    for val in categories[category]:\n",
    "        c+=counts[val]\n",
    "    data_categories[category]=c"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\carol\\anaconda3\\lib\\site-packages\\seaborn\\_decorators.py:36: FutureWarning: Pass the following variables as keyword args: x, y. From version 0.12, the only valid positional argument will be `data`, and passing other arguments without an explicit keyword will result in an error or misinterpretation.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<AxesSubplot:title={'center':'Clinical Study Termination Categories'}>"
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 720x720 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "data_categories=pd.Series(data_categories)\n",
    "plt.figure(figsize=(10,10))\n",
    "plt.title('Clinical Study Termination Categories')\n",
    "sns.barplot(data_categories.index,data_categories.values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {},
   "outputs": [],
   "source": [
    "#https://github.com/shubh809/-Termination-Analysis-on-Terminated-Clinical-Trials\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "from collections import OrderedDict\n",
    "import re\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [
    {
     "ename": "AttributeError",
     "evalue": "type object 'h5py.h5.H5PYConfig' has no attribute '__reduce_cython__'",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mAttributeError\u001b[0m                            Traceback (most recent call last)",
      "\u001b[1;32m<ipython-input-49-76a01d9c502b>\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[1;32m----> 1\u001b[1;33m \u001b[1;32mimport\u001b[0m \u001b[0mspacy\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\spacy\\__init__.py\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[0;32m      8\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m      9\u001b[0m \u001b[1;31m# These are imported as part of the API\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 10\u001b[1;33m \u001b[1;32mfrom\u001b[0m \u001b[0mthinc\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mapi\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mprefer_gpu\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mrequire_gpu\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mrequire_cpu\u001b[0m  \u001b[1;31m# noqa: F401\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     11\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[0mthinc\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mapi\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mConfig\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     12\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\thinc\\api.py\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[0;32m      1\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[1;33m.\u001b[0m\u001b[0mconfig\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mConfig\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mregistry\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mConfigValidationError\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m----> 2\u001b[1;33m \u001b[1;32mfrom\u001b[0m \u001b[1;33m.\u001b[0m\u001b[0minitializers\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mnormal_init\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0muniform_init\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mglorot_uniform_init\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mzero_init\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m      3\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[1;33m.\u001b[0m\u001b[0minitializers\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mconfigure_normal_init\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m      4\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[1;33m.\u001b[0m\u001b[0mloss\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mCategoricalCrossentropy\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mL2Distance\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mCosineDistance\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m      5\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[1;33m.\u001b[0m\u001b[0mloss\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mSequenceCategoricalCrossentropy\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\thinc\\initializers.py\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[0;32m      2\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mnumpy\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m      3\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m----> 4\u001b[1;33m \u001b[1;32mfrom\u001b[0m \u001b[1;33m.\u001b[0m\u001b[0mbackends\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mOps\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m      5\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[1;33m.\u001b[0m\u001b[0mconfig\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mregistry\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m      6\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[1;33m.\u001b[0m\u001b[0mtypes\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mFloatsXd\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mShape\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\thinc\\backends\\__init__.py\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[0;32m      5\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mthreading\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m      6\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m----> 7\u001b[1;33m \u001b[1;32mfrom\u001b[0m \u001b[1;33m.\u001b[0m\u001b[0mops\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mOps\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m      8\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[1;33m.\u001b[0m\u001b[0mcupy_ops\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mCupyOps\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mhas_cupy\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m      9\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[1;33m.\u001b[0m\u001b[0mnumpy_ops\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mNumpyOps\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\thinc\\backends\\ops.py\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[0;32m      8\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[1;33m.\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mtypes\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mFloatsXd\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mInts1d\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mInts2d\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mInts3d\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mInts4d\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mIntsXd\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0m_Floats\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m      9\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[1;33m.\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mtypes\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mDeviceTypes\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mGenerator\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mPadded\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mBatchable\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mSizedGenerator\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 10\u001b[1;33m \u001b[1;32mfrom\u001b[0m \u001b[1;33m.\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mutil\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mget_array_module\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mis_xp_array\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mto_numpy\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     11\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     12\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\thinc\\util.py\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[0;32m     34\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     35\u001b[0m \u001b[1;32mtry\u001b[0m\u001b[1;33m:\u001b[0m  \u001b[1;31m# pragma: no cover\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 36\u001b[1;33m     \u001b[1;32mimport\u001b[0m \u001b[0mtensorflow\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mexperimental\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mdlpack\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     37\u001b[0m     \u001b[1;32mimport\u001b[0m \u001b[0mtensorflow\u001b[0m \u001b[1;32mas\u001b[0m \u001b[0mtf\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     38\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\tensorflow\\__init__.py\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[0;32m     39\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0msys\u001b[0m \u001b[1;32mas\u001b[0m \u001b[0m_sys\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     40\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 41\u001b[1;33m \u001b[1;32mfrom\u001b[0m \u001b[0mtensorflow\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpython\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mtools\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mmodule_util\u001b[0m \u001b[1;32mas\u001b[0m \u001b[0m_module_util\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     42\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[0mtensorflow\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpython\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mutil\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mlazy_loader\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mLazyLoader\u001b[0m \u001b[1;32mas\u001b[0m \u001b[0m_LazyLoader\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     43\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\tensorflow\\python\\__init__.py\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[0;32m     46\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[0mtensorflow\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpython\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mdata\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     47\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[0mtensorflow\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpython\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mdistribute\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 48\u001b[1;33m \u001b[1;32mfrom\u001b[0m \u001b[0mtensorflow\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpython\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mkeras\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     49\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[0mtensorflow\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpython\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mfeature_column\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mfeature_column_lib\u001b[0m \u001b[1;32mas\u001b[0m \u001b[0mfeature_column\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     50\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[0mtensorflow\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpython\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mlayers\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mlayers\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\tensorflow\\python\\keras\\__init__.py\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[0;32m     23\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     24\u001b[0m \u001b[1;31m# See b/110718070#comment18 for more details about this import.\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 25\u001b[1;33m \u001b[1;32mfrom\u001b[0m \u001b[0mtensorflow\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpython\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mkeras\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mmodels\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     26\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     27\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[0mtensorflow\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpython\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mkeras\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mengine\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0minput_layer\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mInput\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\tensorflow\\python\\keras\\models.py\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[0;32m     20\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[0mtensorflow\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpython\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mkeras\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mmetrics\u001b[0m \u001b[1;32mas\u001b[0m \u001b[0mmetrics_module\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     21\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[0mtensorflow\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpython\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mkeras\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0moptimizer_v1\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 22\u001b[1;33m \u001b[1;32mfrom\u001b[0m \u001b[0mtensorflow\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpython\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mkeras\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mengine\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mfunctional\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     23\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[0mtensorflow\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpython\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mkeras\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mengine\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0msequential\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     24\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[0mtensorflow\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpython\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mkeras\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mengine\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mtraining\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\tensorflow\\python\\keras\\engine\\functional.py\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[0;32m     30\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[0mtensorflow\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpython\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mkeras\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mengine\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0minput_spec\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     31\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[0mtensorflow\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpython\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mkeras\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mengine\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mnode\u001b[0m \u001b[1;32mas\u001b[0m \u001b[0mnode_module\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 32\u001b[1;33m \u001b[1;32mfrom\u001b[0m \u001b[0mtensorflow\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpython\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mkeras\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mengine\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mtraining\u001b[0m \u001b[1;32mas\u001b[0m \u001b[0mtraining_lib\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     33\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[0mtensorflow\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpython\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mkeras\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mengine\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mtraining_utils\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     34\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[0mtensorflow\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpython\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mkeras\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0msaving\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0msaved_model\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mnetwork_serialization\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\tensorflow\\python\\keras\\engine\\training.py\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[0;32m     49\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[0mtensorflow\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpython\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mkeras\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mmixed_precision\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mpolicy\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     50\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[0mtensorflow\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpython\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mkeras\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0msaving\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mhdf5_format\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 51\u001b[1;33m \u001b[1;32mfrom\u001b[0m \u001b[0mtensorflow\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpython\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mkeras\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0msaving\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0msave\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     52\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[0mtensorflow\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpython\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mkeras\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0msaving\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0msaving_utils\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     53\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[0mtensorflow\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mpython\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mkeras\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0msaving\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0msaved_model\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mjson_utils\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\tensorflow\\python\\keras\\saving\\save.py\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[0;32m     28\u001b[0m \u001b[1;31m# pylint: disable=g-import-not-at-top\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     29\u001b[0m \u001b[1;32mtry\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 30\u001b[1;33m   \u001b[1;32mimport\u001b[0m \u001b[0mh5py\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     31\u001b[0m \u001b[1;32mexcept\u001b[0m \u001b[0mImportError\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     32\u001b[0m   \u001b[0mh5py\u001b[0m \u001b[1;33m=\u001b[0m \u001b[1;32mNone\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\h5py\\__init__.py\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[0;32m     32\u001b[0m         \u001b[1;32mraise\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     33\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 34\u001b[1;33m \u001b[1;32mfrom\u001b[0m \u001b[1;33m.\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mversion\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     35\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     36\u001b[0m \u001b[1;32mif\u001b[0m \u001b[0mversion\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mhdf5_version_tuple\u001b[0m \u001b[1;33m!=\u001b[0m \u001b[0mversion\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mhdf5_built_version_tuple\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\h5py\\version.py\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[0;32m     15\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     16\u001b[0m \u001b[1;32mfrom\u001b[0m \u001b[0mcollections\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mnamedtuple\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 17\u001b[1;33m \u001b[1;32mfrom\u001b[0m \u001b[1;33m.\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mh5\u001b[0m \u001b[1;32mas\u001b[0m \u001b[0m_h5\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     18\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0msys\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     19\u001b[0m \u001b[1;32mimport\u001b[0m \u001b[0mnumpy\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32mh5py\\h5.pyx\u001b[0m in \u001b[0;36minit h5py.h5\u001b[1;34m()\u001b[0m\n",
      "\u001b[1;31mAttributeError\u001b[0m: type object 'h5py.h5.H5PYConfig' has no attribute '__reduce_cython__'"
     ]
    }
   ],
   "source": [
    "import spacy\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>nct_id</th>\n",
       "      <th>study_type</th>\n",
       "      <th>phase</th>\n",
       "      <th>start_month_year</th>\n",
       "      <th>primary_completion_month_year</th>\n",
       "      <th>has_dmc</th>\n",
       "      <th>overall_status</th>\n",
       "      <th>official_title</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>why_stopped</th>\n",
       "      <th>...</th>\n",
       "      <th>Agency_Class_Lead</th>\n",
       "      <th>lead_or_collaborator</th>\n",
       "      <th>subjects_affected_binary</th>\n",
       "      <th>subjects_at_risk_binary</th>\n",
       "      <th>responsible_party_type</th>\n",
       "      <th>keywords_name</th>\n",
       "      <th>enrollment_bins</th>\n",
       "      <th>minimum_age_bins</th>\n",
       "      <th>maximum_age_bins</th>\n",
       "      <th>stopped</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT04163796</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Not_Provided</td>\n",
       "      <td>1-Aug-18</td>\n",
       "      <td>30-Oct-21</td>\n",
       "      <td>TRUE</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Evaluation of an Upright Powered Wheelchair fo...</td>\n",
       "      <td>UPnRIDE Power Standing Wheelchair for SCI</td>\n",
       "      <td>not stopped/ not stated</td>\n",
       "      <td>...</td>\n",
       "      <td>Other</td>\n",
       "      <td>lead</td>\n",
       "      <td>FALSE</td>\n",
       "      <td>FALSE</td>\n",
       "      <td>Principal Investigator</td>\n",
       "      <td>not_provided</td>\n",
       "      <td>VLOW</td>\n",
       "      <td>Youth</td>\n",
       "      <td>Seniors</td>\n",
       "      <td>not stopped/ not stated</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03264222</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Not_Provided</td>\n",
       "      <td>1-May-17</td>\n",
       "      <td>18-Sep</td>\n",
       "      <td>FALSE</td>\n",
       "      <td>Unknown status</td>\n",
       "      <td>Safety of a New Security Device in Patients Wi...</td>\n",
       "      <td>Safety of a New Security Device in Patients Wi...</td>\n",
       "      <td>not stopped/ not stated</td>\n",
       "      <td>...</td>\n",
       "      <td>Other</td>\n",
       "      <td>collaborator$$lead</td>\n",
       "      <td>FALSE</td>\n",
       "      <td>FALSE</td>\n",
       "      <td>Sponsor</td>\n",
       "      <td>not_provided</td>\n",
       "      <td>VLOW</td>\n",
       "      <td>Youth</td>\n",
       "      <td>no_criteria</td>\n",
       "      <td>not stopped/ not stated</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT02118870</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>10-Jun-14</td>\n",
       "      <td>17-Sep</td>\n",
       "      <td>TRUE</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Randomized Evaluation of Short-term DUal Anti ...</td>\n",
       "      <td>Short-term Dual Anti Platelet Therapy in Patie...</td>\n",
       "      <td>not stopped/ not stated</td>\n",
       "      <td>...</td>\n",
       "      <td>Other</td>\n",
       "      <td>lead</td>\n",
       "      <td>FALSE</td>\n",
       "      <td>FALSE</td>\n",
       "      <td>Sponsor</td>\n",
       "      <td>ACS patients$$Combo stent$$Older than 18 years...</td>\n",
       "      <td>MED</td>\n",
       "      <td>Youth</td>\n",
       "      <td>no_criteria</td>\n",
       "      <td>not stopped/ not stated</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT04175977</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Not_Provided</td>\n",
       "      <td>1-Jan-20</td>\n",
       "      <td>22-Aug</td>\n",
       "      <td>TRUE</td>\n",
       "      <td>Enrolling by invitation</td>\n",
       "      <td>The Hospice Advanced Dementia Symptom Manageme...</td>\n",
       "      <td>The Hospice Advanced Dementia Symptom Manageme...</td>\n",
       "      <td>not stopped/ not stated</td>\n",
       "      <td>...</td>\n",
       "      <td>Other</td>\n",
       "      <td>collaborator$$lead</td>\n",
       "      <td>FALSE</td>\n",
       "      <td>FALSE</td>\n",
       "      <td>Sponsor</td>\n",
       "      <td>not_provided</td>\n",
       "      <td>HIGH</td>\n",
       "      <td>Youth</td>\n",
       "      <td>no_criteria</td>\n",
       "      <td>not stopped/ not stated</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT00682370</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>7-Oct</td>\n",
       "      <td>8-Jul</td>\n",
       "      <td>FALSE</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Dose Escalation, Randomized, Placebo Controlle...</td>\n",
       "      <td>Effects of Heme Arginate in Healthy Male Subjects</td>\n",
       "      <td>not stopped/ not stated</td>\n",
       "      <td>...</td>\n",
       "      <td>Other</td>\n",
       "      <td>lead</td>\n",
       "      <td>FALSE</td>\n",
       "      <td>FALSE</td>\n",
       "      <td>Sponsor-Investigator</td>\n",
       "      <td>not_provided</td>\n",
       "      <td>VLOW</td>\n",
       "      <td>Youth</td>\n",
       "      <td>Adults</td>\n",
       "      <td>not stopped/ not stated</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows Ã— 42 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "        nct_id      study_type         phase start_month_year  \\\n",
       "0  NCT04163796  Interventional  Not_Provided         1-Aug-18   \n",
       "1  NCT03264222  Interventional  Not_Provided         1-May-17   \n",
       "2  NCT02118870  Interventional       Phase 4        10-Jun-14   \n",
       "3  NCT04175977  Interventional  Not_Provided         1-Jan-20   \n",
       "4  NCT00682370  Interventional       Phase 1            7-Oct   \n",
       "\n",
       "  primary_completion_month_year has_dmc           overall_status  \\\n",
       "0                     30-Oct-21    TRUE               Recruiting   \n",
       "1                        18-Sep   FALSE           Unknown status   \n",
       "2                        17-Sep    TRUE                Completed   \n",
       "3                        22-Aug    TRUE  Enrolling by invitation   \n",
       "4                         8-Jul   FALSE                Completed   \n",
       "\n",
       "                                      official_title  \\\n",
       "0  Evaluation of an Upright Powered Wheelchair fo...   \n",
       "1  Safety of a New Security Device in Patients Wi...   \n",
       "2  Randomized Evaluation of Short-term DUal Anti ...   \n",
       "3  The Hospice Advanced Dementia Symptom Manageme...   \n",
       "4  Dose Escalation, Randomized, Placebo Controlle...   \n",
       "\n",
       "                                         brief_title              why_stopped  \\\n",
       "0          UPnRIDE Power Standing Wheelchair for SCI  not stopped/ not stated   \n",
       "1  Safety of a New Security Device in Patients Wi...  not stopped/ not stated   \n",
       "2  Short-term Dual Anti Platelet Therapy in Patie...  not stopped/ not stated   \n",
       "3  The Hospice Advanced Dementia Symptom Manageme...  not stopped/ not stated   \n",
       "4  Effects of Heme Arginate in Healthy Male Subjects  not stopped/ not stated   \n",
       "\n",
       "   ... Agency_Class_Lead lead_or_collaborator subjects_affected_binary  \\\n",
       "0  ...             Other                 lead                    FALSE   \n",
       "1  ...             Other   collaborator$$lead                    FALSE   \n",
       "2  ...             Other                 lead                    FALSE   \n",
       "3  ...             Other   collaborator$$lead                    FALSE   \n",
       "4  ...             Other                 lead                    FALSE   \n",
       "\n",
       "  subjects_at_risk_binary  responsible_party_type  \\\n",
       "0                   FALSE  Principal Investigator   \n",
       "1                   FALSE                 Sponsor   \n",
       "2                   FALSE                 Sponsor   \n",
       "3                   FALSE                 Sponsor   \n",
       "4                   FALSE    Sponsor-Investigator   \n",
       "\n",
       "                                       keywords_name enrollment_bins  \\\n",
       "0                                       not_provided            VLOW   \n",
       "1                                       not_provided            VLOW   \n",
       "2  ACS patients$$Combo stent$$Older than 18 years...             MED   \n",
       "3                                       not_provided            HIGH   \n",
       "4                                       not_provided            VLOW   \n",
       "\n",
       "  minimum_age_bins maximum_age_bins                  stopped  \n",
       "0            Youth          Seniors  not stopped/ not stated  \n",
       "1            Youth      no_criteria  not stopped/ not stated  \n",
       "2            Youth      no_criteria  not stopped/ not stated  \n",
       "3            Youth      no_criteria  not stopped/ not stated  \n",
       "4            Youth           Adults  not stopped/ not stated  \n",
       "\n",
       "[5 rows x 42 columns]"
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dataset.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Create search_terms column containing relevant text columns \n",
    "dataset['search_terms'] = dataset['condition_name'].apply(str)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Remove duplicate words from string\n",
    "def set_o_strings(strings):\n",
    "    new = OrderedDict()\n",
    "    for string in strings.split():\n",
    "        new[string] = ''\n",
    "    return u\" \".join(new.keys())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Remove missing from search terms, replace with blank space\n",
    "def replace_missing(string):\n",
    "    new = re.sub(' missing', '', string)\n",
    "    return u\"{}\".format(new)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Apply above functions to search terms\n",
    "dataset['search_terms'] = dataset['search_terms'].apply(replace_missing)\n",
    "dataset['search_terms'] = dataset['search_terms'].apply(set_o_strings)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0                                  Spinal Cord Injuries\n",
       "1                          Electromagnetic Interference\n",
       "2                               Acute Coronary Syndrome\n",
       "3                                              Dementia\n",
       "4     Genetic Polymorphism$$Healthy Subjects$$Heme O...\n",
       "                            ...                        \n",
       "95    Cardiovascular Diseases$$Mediterranean Diet$$M...\n",
       "96                                             Epilepsy\n",
       "97                                               Stroke\n",
       "98                        Cardiovascular Risk Reduction\n",
       "99                                    Colorectal Cancer\n",
       "Name: search_terms, Length: 100, dtype: object"
      ]
     },
     "execution_count": 45,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dataset['search_terms'].head(100)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [
    {
     "ename": "NameError",
     "evalue": "name 'nlp' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mNameError\u001b[0m                                 Traceback (most recent call last)",
      "\u001b[1;32m<ipython-input-46-109b69809fcd>\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[0;32m      1\u001b[0m \u001b[1;31m# Tokenize search terms\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m----> 2\u001b[1;33m \u001b[0mdataset\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;34m'keyword_tokens'\u001b[0m\u001b[1;33m]\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mdataset\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;34m'search_terms'\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mapply\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;32mlambda\u001b[0m \u001b[0mx\u001b[0m\u001b[1;33m:\u001b[0m \u001b[0mnlp\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mtokenizer\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mx\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\pandas\\core\\series.py\u001b[0m in \u001b[0;36mapply\u001b[1;34m(self, func, convert_dtype, args, **kwds)\u001b[0m\n\u001b[0;32m   4198\u001b[0m     \u001b[1;36m3\u001b[0m    \u001b[1;36m4\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m   4199\u001b[0m     \u001b[0mdtype\u001b[0m\u001b[1;33m:\u001b[0m \u001b[0mint64\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m-> 4200\u001b[1;33m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m   4201\u001b[0m     \u001b[1;33m>>\u001b[0m\u001b[1;33m>\u001b[0m \u001b[0ms\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0magg\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;34m'min'\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m   4202\u001b[0m     \u001b[1;36m1\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\anaconda3\\lib\\site-packages\\pandas\\_libs\\lib.pyx\u001b[0m in \u001b[0;36mpandas._libs.lib.map_infer\u001b[1;34m()\u001b[0m\n",
      "\u001b[1;32m<ipython-input-46-109b69809fcd>\u001b[0m in \u001b[0;36m<lambda>\u001b[1;34m(x)\u001b[0m\n\u001b[0;32m      1\u001b[0m \u001b[1;31m# Tokenize search terms\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m----> 2\u001b[1;33m \u001b[0mdataset\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;34m'keyword_tokens'\u001b[0m\u001b[1;33m]\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mdataset\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;34m'search_terms'\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mapply\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;32mlambda\u001b[0m \u001b[0mx\u001b[0m\u001b[1;33m:\u001b[0m \u001b[0mnlp\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mtokenizer\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mx\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m",
      "\u001b[1;31mNameError\u001b[0m: name 'nlp' is not defined"
     ]
    }
   ],
   "source": [
    "# Tokenize search terms\n",
    "dataset['keyword_tokens'] = dataset['search_terms'].apply(lambda x: nlp.tokenizer(x))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0                              (Spinal, Cord, Injuries)\n",
       "1                       (Electromagnetic, Interference)\n",
       "2                           (Acute, Coronary, Syndrome)\n",
       "3                                     (Low, Back, Pain)\n",
       "4                                            (Dementia)\n",
       "5     (Genetic, Polymorphism$$Healthy, Subjects$$Hem...\n",
       "6                                    (Prostate, Cancer)\n",
       "7     (Age, -, related, Macular, Degeneration$$Neova...\n",
       "8                                             (Obesity)\n",
       "9                                 (Healthy, Volunteers)\n",
       "10                   (Partial, Tear, of, Rotator, Cuff)\n",
       "11                            (Poor, Ovarian, Response)\n",
       "12    (End, Stage, Renal, Disease$$Kidney, Diseases$...\n",
       "13                                   (Cystic, Fibrosis)\n",
       "14                                (Healthy, Volunteers)\n",
       "15                                    (Type2, Diabetes)\n",
       "16      (Gastroesophageal, Reflux, Disease, (, GERD, ))\n",
       "17    (Acute, Graft, Rejection$$Disorder, Related, t...\n",
       "18                                          (Psychosis)\n",
       "19                             (Vestibular, Schwannoma)\n",
       "20            (Cancer$$Posttraumatic, Stress, Disorder)\n",
       "21                                 (Obesity, ,, Morbid)\n",
       "22    (Hypercholesterolemia$$Osteoporosis$$Postmenop...\n",
       "23                              (Sleep, Apnea$$Snoring)\n",
       "24    (Fracture, Healing$$Tibial, Fractures$$Vitamin...\n",
       "25    (Primary, Open, Angle, Glaucoma$$Secondary, Gl...\n",
       "26                                  (Type, 1, Diabetes)\n",
       "27                     (Amyloidosis$$Multiple, Myeloma)\n",
       "28                            (Cardiovascular, Disease)\n",
       "29    (Behavior, Disorders$$Emotional, Disturbances$...\n",
       "30    (Adrenaline$$Blood, Transfusion$$Dopamine$$Sho...\n",
       "31                               (Upper, Body, Obesity)\n",
       "32                                             (Myopia)\n",
       "33                                 (Domestic, Violence)\n",
       "34                             (Vitamin, D, Deficiency)\n",
       "35                              (Enrichment, of, Blood)\n",
       "36                      (Heart, Defects, ,, Congenital)\n",
       "37                                 (Pancreatic, Cancer)\n",
       "38                                             (Asthma)\n",
       "39                       (Atrial, High, Rate, Episodes)\n",
       "40    (Low, -, grade, Serous, Ovarian, Carcinoma$$Re...\n",
       "41                 (Alzheimer, Disease$$Healthy, Aging)\n",
       "42                             (Alzheimer, 's, Disease)\n",
       "43                                  (Coronary, Disease)\n",
       "44    (Mesothelioma$$Pleural, Mesothelioma$$Wilms, T...\n",
       "45                           (Diabetic, Macular, Edema)\n",
       "46                                     (HIV, Infection)\n",
       "47                  (Non, -, Small, Cell, Lung, Cancer)\n",
       "48                        (Polycystic, Ovary, Syndrome)\n",
       "49                (Rhinitis, ,, Allergic, ,, Perennial)\n",
       "Name: keyword_tokens, dtype: object"
      ]
     },
     "execution_count": 53,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dataset['keyword_tokens'].head(50)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
